Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell line enhanced" "Detected in many" "A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.7 19.9 5.9 0.0 0.2 0.0 34.7 0.7 0.6 1.0 1.7 4.4 0.2 0.0 0.2 0.1 5.8 0.2 0.6 1.5 5.6 0.9 0.2 0.1 5.9 0.0 0.3 0.0 0.1 2.4 2.3 0.1 1.8 0.4 0.0 0.6 11.5 2.7 0.1 2.0 0.0 1.3 0.0 17.4 0.0 4.2 0.1 0.2 4.1 0.4 0.5 0.1 0.0 0.0 0.8 0.7 0.2 0.0 5.5 2.1 0.0 1.5 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA029973, HPA068407" Approved Enhanced "Plasma membrane,Cell Junctions,Cytosol" 400000 "Plasma membrane, Cell Junctions" Cytosol "CAB008375: AB_592744, HPA029973: , HPA068407: " "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 24.0 14.0 32.0 28.1 32.6 54.1 21.4 28.2 35.5 22.5 22.7 19.8 14.8 24.8 23.9 15.4 45.1 20.3 21.6 14.1 47.3 23.1 21.9 17.8 22.5 32.1 25.0 26.4 25.3 17.0 19.1 14.4 22.7 20.9 19.1 24.8 26.7 30.9 17.0 16.6 33.0 26.0 21.6 27.5 25.5 23.9 12.4 20.5 43.5 18.8 27.3 40.9 25.2 30.3 36.1 26.8 51.5 28.0 20.5 44.5 31.5 23.2 13.1 10.7 10.5 16.2 20.0 16.0 23.6 16.1 17.5 20.4 15.3 27.6 42.8 12.1 25.0 26.1 12.9 15.3 19.5 28.5 11.5 18.8 8.9 10.8 11.1 9.1 19.0 13.6 19.5 17.1 10.2 21.1 13.8 27.4 17.8 10.0 21.3 8.7 8.8 6.3 23.1 19.9 27.5 18.6 10.8 8.9 9.5 19.6 19.2 19.7 12.4 14.5 26.2 13.4 16.5 16.9 12.0 6.1 9.8 50.9 19.3 23.3 9.6 35.5 23.8 51.5 27.0 28.0 25.8 36.1 25.9 30.0 26.8 28.6 24.4 26.5 37.9 20.5 26.7 22.3 44.5 31.5 32.0 32.6 28.2 31.9 47.3 23.1 25.0 26.4 20.9 20.5 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" 1400000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favourable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favourable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 44.0 31.7 43.1 27.9 52.1 26.7 35.6 46.3 66.6 37.5 43.3 47.2 27.3 30.8 47.9 29.2 35.1 43.0 33.1 41.1 39.5 34.1 36.8 23.4 38.0 27.9 40.5 46.7 65.3 25.0 31.3 28.4 31.2 44.7 43.1 30.7 36.3 26.2 54.9 69.5 25.5 33.6 58.1 33.8 34.9 32.6 25.2 37.0 25.5 27.9 19.6 28.5 45.3 34.9 21.3 16.2 21.5 6.5 16.4 12.9 9.1 18.3 15.4 36.7 18.9 54.4 40.7 13.8 31.2 37.5 32.6 27.6 22.6 23.4 9.6 16.4 53.4 11.8 27.4 26.2 27.3 12.3 12.6 27.2 13.4 21.8 26.6 16.1 19.4 40.1 24.6 28.6 11.5 40.5 28.2 23.4 37.0 10.8 49.6 22.6 20.6 21.9 22.0 20.3 11.3 23.8 40.8 22.0 28.6 22.5 9.2 19.3 21.6 15.4 48.8 26.7 13.8 21.8 25.7 18.8 15.2 12.3 25.7 20.1 25.7 11.0 4.8 21.5 12.9 4.5 11.8 16.1 7.2 10.8 7.5 21.3 6.8 8.1 6.7 16.4 6.5 16.2 9.2 9.1 43.1 52.1 46.3 66.6 39.5 34.1 40.5 46.7 44.7 37.0 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: " "prognostic unfavourable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 19.4 6.1 42.4 15.1 4.1 3.5 31.6 7.9 4.0 6.8 8.5 25.9 12.1 3.4 14.7 4.7 9.4 17.6 16.2 12.3 21.9 18.2 0.1 2.6 19.6 6.2 2.1 9.3 2.4 10.9 11.5 27.1 12.6 38.9 13.6 4.4 8.3 0.2 0.1 10.4 2.8 12.5 11.1 14.7 12.5 9.5 19.7 12.0 8.0 30.5 12.0 3.6 0.8 18.5 3.2 15.4 13.7 13.0 0.2 16.5 7.1 9.5 4.5 27.8 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 84.9;fHDF/TERT166: 79.0;TIME: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" 950000 "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavourable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (3.47e-6)" 85.2 8.2 15.3 35.3 9.3 10.0 91.1 9.3 10.8 69.7 66.3 16.8 36.4 13.0 52.2 47.4 96.9 39.4 59.2 55.8 20.9 6.0 18.4 16.0 54.9 16.6 16.2 13.4 40.2 8.9 8.0 5.3 39.8 15.9 42.6 26.8 29.6 35.5 36.8 64.8 88.4 38.2 101.5 16.1 16.9 38.3 16.9 16.2 5.8 18.4 72.9 44.0 54.3 86.1 8.2 28.9 15.3 30.1 11.1 16.7 12.2 26.0 15.4 1.4 6.4 63.3 84.9 10.2 23.7 29.1 15.1 8.5 13.2 9.3 0.0 9.0 79.0 34.8 5.9 29.2 19.4 21.1 0.9 3.1 22.9 3.9 12.1 4.3 20.8 30.6 34.3 29.7 27.2 31.1 2.9 20.2 30.6 10.1 0.0 8.4 0.4 23.4 0.0 6.5 15.6 33.6 17.1 0.0 1.3 23.9 10.1 10.1 19.4 4.0 82.6 27.0 17.6 33.5 10.4 3.6 0.7 0.0 20.5 1.4 8.8 15.3 30.1 0.1 16.7 17.5 11.0 8.2 10.7 13.1 28.9 5.2 1.4 7.6 0.4 11.1 14.0 7.9 7.9 12.2 15.3 9.3 9.3 10.8 20.9 6.0 16.2 13.4 15.9 16.2 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: " "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 19.7 0.0 1.3 28.1 32.0 0.0 2.4 5.0 0.8 0.4 0.0 8.8 0.0 3.3 18.5 14.2 0.0 28.1 0.4 0.0 0.1 0.0 13.0 0.1 2.6 0.0 0.9 4.1 70.8 2.8 30.2 12.3 0.0 0.0 14.2 1.6 0.0 0.0 0.0 9.7 0.0 1.3 0.0 19.2 0.0 0.1 0.1 10.4 0.0 0.4 1.3 0.0 31.7 6.8 4.2 7.7 2.1 0.0 0.0 0.0 20.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 AKAP12 "AKAP250, SSeCKS" ENSG00000131016 "A-kinase anchoring protein 12" Q02952 6 151239999-151358557 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 43.1;TIME: 42.9;U-251 MG: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 184 "basophil: 20.4" "Lineage enriched" "Detected in single" 184 "granulocytes: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006344, CAB026379, HPA056230" Enhanced Enhanced "Plasma membrane,Cytosol" 6400000 "Plasma membrane, Cytosol" "CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (9.90e-3)" "prognostic unfavourable (7.08e-4)" "unprognostic (2.61e-2)" "unprognostic (8.88e-2)" "unprognostic (5.05e-2)" "prognostic unfavourable (6.34e-5)" "unprognostic (1.34e-1)" "unprognostic (8.26e-3)" "unprognostic (2.59e-1)" "unprognostic (4.72e-2)" "unprognostic (4.51e-3)" "unprognostic (1.10e-3)" "unprognostic (3.51e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-2)" 52.5 11.2 11.5 11.0 18.1 2.0 38.5 31.3 21.2 11.5 23.4 1.9 5.9 6.1 20.5 13.6 12.8 15.6 32.3 22.8 9.8 17.4 14.9 20.6 18.2 6.9 11.4 9.9 49.0 7.6 2.0 11.1 24.1 28.7 13.5 9.4 26.6 3.3 14.7 11.3 4.1 10.6 27.9 14.1 8.1 12.4 62.0 6.6 0.3 11.4 6.6 2.8 34.5 24.7 0.0 0.0 20.4 0.0 0.0 0.1 0.0 1.7 8.6 12.4 0.0 23.4 35.1 4.3 10.0 5.4 4.5 4.5 0.2 32.5 0.0 4.0 7.5 0.2 23.5 7.4 4.0 11.1 8.6 0.1 9.6 7.9 2.6 0.0 2.2 24.8 0.0 19.1 1.0 29.4 2.1 0.2 16.3 0.1 0.0 0.0 7.7 10.1 43.1 0.5 0.0 26.1 1.4 8.8 5.1 3.2 0.1 5.7 0.6 0.1 42.9 0.6 8.0 25.6 45.9 0.0 0.0 0.0 14.9 0.0 8.6 20.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.1 31.3 19.1 9.8 17.4 11.4 9.9 28.7 6.6 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: " "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.7 6.0 10.5 16.0 17.5 7.0 10.5 6.1 9.2 1.1 7.9 4.8 5.7 6.9 3.7 2.7 12.5 8.8 10.0 4.7 4.2 3.0 5.4 8.2 2.5 8.3 16.5 16.9 7.4 7.6 6.8 4.1 8.1 7.0 3.1 4.3 6.4 3.1 2.9 2.6 6.2 6.6 4.8 6.4 7.7 6.0 5.3 4.3 8.3 6.4 4.1 8.5 2.5 3.0 3.9 5.0 15.8 11.4 4.1 6.2 4.1 7.1 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: , HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favourable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favourable (4.57e-5)" "prognostic unfavourable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 65.9 104.2 4.7 4.9 66.5 63.3 0.3 114.3 71.4 47.3 32.1 3.0 59.7 0.1 37.8 99.7 81.2 10.1 69.2 37.5 37.3 0.7 5.0 31.0 0.1 53.1 11.0 2.5 36.4 57.4 47.8 94.0 67.0 20.9 2.8 58.3 0.2 19.4 6.0 5.9 42.4 0.0 26.6 0.2 106.4 14.0 0.0 0.0 39.3 1.0 26.4 0.2 1.7 82.7 55.5 34.9 76.2 58.6 0.4 0.1 0.2 128.1 10.2 83.4 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438203-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2;lymphoid tissue: 100.5" "Cell line enhanced" "Detected in many" "Daudi: 25.2;MOLT-4: 21.6;REH: 48.6;U-698: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA017009: , HPA063903: " "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favourable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 18.3 3.9 7.9 27.7 14.2 25.8 10.1 1.2 7.3 2.6 3.9 16.6 0.0 4.5 2.0 1.5 2.9 4.9 7.5 4.8 7.3 4.9 4.8 25.4 11.1 28.2 14.5 3.2 1.5 3.0 1.3 2.7 5.5 11.1 2.5 4.5 1.6 4.0 1.6 1.5 2.8 12.0 4.7 21.9 41.5 5.4 1.3 12.1 100.5 3.0 0.7 26.2 8.0 3.9 11.0 14.8 54.2 10.3 5.3 9.5 3.5 0.0 0.4 0.0 0.0 3.4 5.6 2.9 9.4 1.8 5.4 5.2 0.0 0.0 25.2 0.1 6.2 0.0 0.0 0.0 7.5 0.0 0.0 18.2 0.0 0.0 0.0 3.4 0.0 8.0 0.0 0.1 0.0 0.0 0.0 16.0 0.0 0.0 21.6 4.8 0.0 0.0 48.6 0.0 17.8 1.5 0.0 0.0 0.0 0.8 0.1 0.0 0.0 11.9 0.0 0.0 0.1 1.7 0.0 4.4 0.0 51.7 4.4 17.8 0.0 19.0 7.1 16.1 9.5 6.9 7.7 9.5 8.1 7.9 4.4 11.0 9.3 9.0 54.2 5.3 10.3 14.8 7.6 3.5 7.9 14.2 1.2 7.3 7.3 4.9 14.5 3.2 11.1 12.1 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA035777: , HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 5.6 3.7 5.6 8.8 7.6 18.3 8.6 7.2 5.3 7.4 5.1 11.7 3.2 4.1 6.9 3.4 6.1 6.0 4.0 4.9 5.7 4.6 4.6 3.2 5.5 14.1 10.9 3.6 11.4 3.4 8.0 7.3 6.0 7.4 5.8 5.3 7.3 6.4 3.7 4.0 6.0 6.6 5.3 14.2 12.0 4.3 20.1 7.0 30.4 4.4 5.5 14.3 6.7 5.9 5.5 5.3 15.5 7.3 4.1 6.0 5.1 8.2 2.7 14.9 26.0 1.0 3.9 4.6 4.1 4.2 6.6 4.6 5.3 7.5 18.5 3.5 2.8 5.6 12.5 5.1 8.4 9.2 6.8 12.1 3.4 3.5 0.9 18.7 13.0 2.0 1.8 4.6 10.6 8.9 12.0 9.8 5.7 4.1 16.9 4.0 8.0 2.5 20.4 12.7 5.2 2.0 3.7 1.1 6.9 3.0 1.5 6.8 9.2 9.8 4.1 2.7 3.2 4.1 10.6 8.8 9.0 25.0 3.4 22.1 2.9 15.3 7.3 10.2 5.2 6.6 4.9 5.5 5.1 4.8 5.3 5.5 6.0 5.3 15.5 4.1 5.7 3.0 5.9 5.1 5.6 7.6 7.2 5.3 5.7 4.6 10.9 3.6 7.4 7.0 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell line enhanced" "Detected in many" "K-562: 15.4;SCLC-21H: 14.7;SH-SY5Y: 11.3;U-2 OS: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: , HPA063675: " "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favourable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.2 0.3 4.4 5.7 0.0 0.0 4.6 0.8 0.3 0.2 0.5 0.9 0.7 1.3 3.6 0.4 3.0 0.7 1.4 0.0 0.4 5.5 0.4 0.3 3.4 1.3 0.4 1.0 0.1 0.5 0.2 0.2 3.6 15.4 0.4 0.0 2.9 0.2 2.0 4.5 1.8 8.2 0.2 0.4 0.8 0.7 14.7 11.3 0.9 1.4 2.2 1.2 0.3 1.3 0.1 12.9 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311817-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Enhanced "Plasma membrane,Cytosol" 3400000 "Plasma membrane, Cytosol" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavourable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavourable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 19.4 27.4 21.1 23.0 28.4 16.9 24.8 12.1 32.3 20.6 26.7 29.1 18.1 23.4 27.9 15.6 19.1 21.9 19.1 18.2 20.3 21.1 23.1 35.6 17.3 36.1 29.7 19.9 23.4 32.9 25.1 21.1 31.1 24.4 21.9 35.9 19.5 14.4 29.4 35.5 17.0 20.6 26.7 21.7 29.0 20.4 15.0 28.0 46.3 16.1 13.5 35.3 27.6 18.0 21.7 13.4 2.9 8.9 19.6 22.8 10.0 20.2 30.7 17.1 29.1 23.0 23.3 8.6 20.7 18.0 23.7 27.2 59.1 31.8 29.5 25.7 21.6 21.3 37.6 31.2 34.0 21.9 36.4 35.9 26.3 53.0 29.8 44.9 18.4 19.7 24.0 31.6 38.2 15.8 46.3 24.6 32.5 29.9 39.1 21.8 65.9 17.2 36.4 24.7 26.4 25.1 32.7 26.9 18.6 16.6 20.5 23.4 33.6 16.0 13.9 20.1 20.8 25.9 13.0 31.1 40.6 61.2 17.5 25.1 29.0 2.9 6.0 0.1 13.2 8.9 22.8 21.7 18.6 20.0 13.4 13.2 18.9 17.5 0.7 19.6 7.4 11.7 17.7 10.0 21.1 28.4 12.1 32.3 20.3 21.1 29.7 19.9 24.4 28.0 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57941541-57957269 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell line enhanced" "Detected in many" "NB-4: 14.8;RH-30: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: " "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.7 4.9 4.3 5.2 5.3 11.3 4.8 6.1 4.8 5.6 8.2 1.3 2.5 3.9 3.2 4.2 7.3 3.1 2.4 6.4 4.2 3.6 5.4 6.2 2.7 6.8 2.7 3.8 4.2 5.8 3.2 3.0 3.5 2.9 5.1 8.2 2.3 3.4 3.3 11.7 5.6 4.3 6.5 3.4 3.7 3.8 39.5 2.0 20.8 4.7 5.9 4.7 6.3 6.2 3.0 4.5 12.0 4.5 2.6 5.6 3.0 1.9 1.5 1.9 2.2 2.8 2.7 1.0 1.9 1.9 2.2 2.1 1.2 2.4 6.8 2.4 1.4 1.8 1.8 1.9 3.8 3.4 1.8 4.4 1.2 1.9 1.2 8.9 3.0 1.4 1.5 1.3 0.5 1.5 4.6 4.9 1.8 3.0 4.8 14.8 1.6 3.7 3.1 48.8 2.8 1.8 2.5 1.2 1.8 3.0 2.8 1.5 4.9 8.4 0.8 1.6 2.8 2.1 1.8 4.0 2.1 3.5 1.8 9.6 2.7 7.6 4.5 12.0 3.5 2.4 2.6 3.0 4.0 3.3 4.5 3.0 4.3 4.0 1.9 2.6 4.2 2.1 5.6 3.0 4.3 5.3 6.1 4.8 4.2 3.6 2.7 3.8 2.9 2.0 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711477-44718877 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Immunity "Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" 3200000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 127.2 50.9 24.2 109.2 29.8 131.1 85.2 11.8 23.1 70.5 111.4 29.1 43.3 79.1 72.7 74.7 80.5 36.8 112.8 73.6 26.0 23.1 109.7 140.3 191.2 172.1 42.2 18.8 54.8 42.7 7.8 40.5 91.9 33.1 78.7 128.9 53.5 121.5 40.9 45.7 94.1 178.5 55.1 56.7 272.8 52.5 30.0 29.5 108.0 97.7 71.5 131.6 135.9 73.5 138.9 74.9 341.3 132.8 128.8 215.8 323.7 33.1 14.7 1.4 8.3 54.6 73.6 52.1 22.0 44.9 35.8 60.9 19.1 77.4 15.8 31.1 21.4 29.3 5.5 9.8 17.2 110.7 13.0 60.2 89.2 22.1 41.6 33.7 36.1 37.2 9.1 11.0 11.8 24.4 15.3 2.2 39.6 17.7 13.8 89.0 2.4 31.4 16.8 36.0 100.3 31.2 137.5 5.8 2.1 23.0 18.7 25.9 6.2 175.3 48.5 70.3 7.8 92.6 42.9 41.0 93.8 29.5 68.5 111.3 33.6 221.2 90.4 210.9 126.8 132.8 125.9 138.9 171.7 141.1 58.9 109.4 137.0 167.5 341.3 128.8 106.5 74.9 215.8 323.7 24.2 29.8 11.8 23.1 26.0 23.1 42.2 18.8 33.1 29.5 BAG3 ENSG00000151929 "BCL2 associated athanogene 3" O95817 10 119651370-119677819 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 115.2;vagina: 160.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.6" "Lineage enriched" "Detected in many" 7 "T-cells: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Enhanced "Plasma membrane,Cytosol" 890000 "Plasma membrane, Cytosol" "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 17.8 14.1 18.8 7.7 25.7 2.7 38.3 18.4 20.7 11.7 14.1 7.3 6.5 6.3 10.1 10.6 23.3 8.7 17.0 38.2 20.6 14.3 16.8 10.1 14.3 5.9 20.9 4.5 7.3 9.3 27.6 8.8 16.5 27.4 14.4 6.7 5.5 14.6 12.9 115.2 18.5 5.6 20.4 35.8 4.4 15.1 8.1 20.6 1.3 11.1 32.7 12.8 14.0 160.1 0.3 0.8 0.4 1.1 0.2 7.6 1.0 26.1 29.8 8.3 10.8 21.6 15.2 15.6 23.9 20.3 18.3 15.8 12.6 12.8 1.0 11.4 20.5 39.1 8.5 42.2 12.7 12.8 14.0 1.4 8.0 15.7 18.3 0.0 6.1 15.3 24.4 13.3 21.1 20.4 11.2 6.5 18.2 37.4 1.4 5.8 3.2 34.1 0.0 11.8 4.5 13.8 5.9 1.5 1.4 9.5 16.9 12.4 10.5 3.5 25.4 9.7 8.4 13.1 34.1 6.0 3.5 0.6 18.1 0.4 7.3 0.0 1.0 0.0 1.2 1.1 2.0 0.3 4.4 1.5 0.8 0.0 7.6 2.7 0.4 0.2 0.5 0.2 3.0 1.0 18.8 25.7 18.4 20.7 20.6 14.3 20.9 4.5 27.4 20.6 BAIAP2 "BAP2, IRSp53" ENSG00000175866 "BAI1 associated protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavourable (7.58e-6)" 10.1 10.9 29.0 4.1 37.4 1.7 11.5 19.6 45.3 14.6 11.8 11.4 18.0 4.3 10.1 26.0 45.9 20.6 17.6 8.7 22.1 10.6 20.6 26.3 20.0 3.6 7.3 24.3 5.1 7.6 8.4 19.2 17.0 9.8 25.7 7.1 11.8 17.0 17.1 3.9 52.6 4.9 10.8 5.4 6.2 20.1 9.2 12.3 2.1 10.2 20.1 20.2 11.1 20.5 0.1 15.4 4.8 7.8 1.3 2.7 2.3 29.9 13.8 8.9 11.5 7.1 9.5 10.3 12.4 8.1 11.2 5.0 18.7 15.2 0.1 9.0 10.9 29.2 8.1 14.2 4.3 0.1 10.2 6.1 12.2 13.9 6.6 0.0 8.9 4.0 16.8 9.2 4.9 6.0 7.8 0.2 6.4 15.9 1.2 6.7 3.7 12.2 1.8 2.2 24.6 34.3 10.5 11.7 12.8 19.8 28.7 33.3 25.2 6.9 7.3 26.2 24.9 4.3 13.1 0.4 0.1 0.4 22.8 1.0 5.6 0.0 5.9 0.4 2.7 7.8 0.9 0.1 1.0 0.9 8.3 0.1 1.2 1.5 4.8 1.3 7.2 15.4 0.4 2.3 29.0 37.4 19.6 45.3 22.1 10.6 7.3 24.3 9.8 12.3 BAIAP2L1 IRTKS ENSG00000006453 "BAI1 associated protein 2 like 1" Q9UHR4 7 98291651-98401068 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 4.7 11.2 1.3 16.9 1.1 0.0 10.3 0.3 0.9 6.1 27.3 1.1 10.8 16.2 3.6 4.7 17.9 6.8 29.6 2.1 0.7 0.6 8.9 31.0 15.4 0.9 0.8 0.2 2.6 47.4 4.7 16.9 17.0 1.2 15.2 12.5 6.5 14.7 12.3 3.3 11.3 34.0 3.4 0.7 1.4 33.0 11.6 0.4 2.1 18.0 11.2 14.1 18.9 12.9 1.3 2.7 0.1 0.2 0.0 0.9 0.1 16.0 12.8 0.3 0.3 0.0 0.6 21.5 4.1 2.7 2.2 1.6 17.7 24.2 0.7 6.2 1.5 14.3 6.0 17.6 2.0 0.0 7.7 0.0 5.5 10.1 2.7 0.0 5.8 0.6 23.9 1.2 17.6 0.0 9.5 0.0 1.8 13.5 0.0 0.0 10.1 6.9 0.0 0.2 2.6 13.7 14.2 9.2 1.8 9.6 28.0 4.9 7.8 0.4 0.5 3.2 15.6 0.6 1.9 0.3 4.8 8.1 0.3 2.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.3 0.9 0.2 0.1 0.0 0.2 2.7 0.1 0.1 1.3 1.1 0.3 0.9 0.7 0.6 0.8 0.2 1.2 0.4 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.3;epididymis: 126.9" "Cell line enhanced" "Detected in many" "HeLa: 113.7;SiHa: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 42.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 42.4" "Low region specificity" "Detected in many" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" 85000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: " "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 9.2 6.7 64.3 28.4 37.4 31.1 4.8 37.2 107.3 16.2 5.2 4.0 15.1 3.8 15.5 126.9 4.0 3.6 12.7 4.4 65.0 55.8 4.2 7.7 9.1 30.2 30.1 56.6 11.7 2.5 3.6 6.4 36.4 21.9 32.2 5.5 7.9 3.8 11.5 1.6 6.0 5.7 14.2 11.0 21.9 9.2 2.2 4.3 3.7 3.6 1.3 35.4 17.6 13.0 2.5 1.6 42.4 1.1 0.6 0.1 0.2 0.0 17.0 21.2 0.0 10.2 10.9 30.4 21.2 7.0 17.9 19.0 0.8 0.0 6.6 3.0 15.2 1.4 13.5 14.8 23.3 2.7 7.6 0.0 113.7 0.0 22.7 13.1 0.1 18.7 18.5 20.2 17.0 19.3 0.0 0.0 19.0 24.4 0.0 12.0 15.6 5.2 0.0 0.0 3.6 6.4 4.2 13.6 2.8 109.2 10.0 0.0 0.0 13.6 24.6 23.7 0.0 1.9 3.4 0.2 0.0 3.5 23.9 16.3 3.1 6.2 1.1 7.8 0.0 0.4 0.0 1.8 0.0 0.0 1.6 2.5 0.0 0.0 42.4 0.6 0.6 0.1 0.1 0.2 64.3 37.4 37.2 107.3 65.0 55.8 30.1 56.6 21.9 4.3 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell line enhanced" "Detected in some" "A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favourable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 17.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 31.8 0.0 2.1 0.0 39.2 0.0 37.7 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.0 0.0 11.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 18.4 4.7 0.0 0.1 0.3 3.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell line enhanced" "Detected in some" "A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in all" "CAB005100, CAB017107, HPA055207" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB005100: AB_2066539, CAB017107: , HPA055207: " "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favourable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970728 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 224.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 78.6;fHDF/TERT166: 127.8;U-138 MG: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" 110000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 38.6 17.4 6.7 33.4 11.1 0.0 26.6 11.9 9.1 83.1 141.0 6.0 111.4 12.6 82.3 59.8 122.8 45.8 46.3 20.1 7.7 5.0 33.5 39.6 26.1 12.9 8.7 8.5 76.3 6.9 4.1 17.8 57.4 8.9 87.8 25.1 10.9 12.4 133.3 15.3 12.9 39.2 224.5 8.5 35.9 64.5 29.7 9.7 2.1 20.3 14.1 5.3 205.3 70.4 0.1 0.2 4.3 0.2 0.4 0.2 5.9 12.0 7.9 17.9 15.7 62.2 50.4 17.7 70.9 78.6 24.4 27.1 14.4 0.3 0.0 16.9 127.8 2.8 11.4 21.1 33.2 0.1 3.8 0.4 9.4 9.7 40.9 0.0 0.0 38.7 15.7 27.3 15.4 20.5 0.0 0.1 36.4 0.0 0.0 0.2 21.4 2.7 0.1 15.9 0.0 5.0 3.2 3.1 7.8 24.9 3.3 9.5 0.7 0.1 54.7 82.0 14.3 15.5 24.1 0.0 0.0 0.0 28.5 0.0 61.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 4.3 0.4 0.0 0.0 0.0 5.9 6.7 11.1 11.9 9.1 7.7 5.0 8.7 8.5 8.9 9.7 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834302-191847255 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 27.6;HEL: 20.1;HUVEC TERT2: 62.5;LHCN-M2: 96.9;TIME: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 9.9;neutrophil: 8.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" 160000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: " "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favourable (8.45e-5)" "prognostic unfavourable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 60.3 8.9 4.9 10.1 8.3 1.8 37.8 2.8 6.1 26.1 32.6 2.8 14.5 3.9 23.9 17.4 18.2 19.5 45.3 46.5 7.1 5.3 15.9 10.4 57.9 20.1 8.9 5.6 20.4 7.6 3.2 4.3 11.6 5.8 19.3 8.9 9.8 6.9 11.2 35.7 3.8 10.6 39.3 7.1 52.9 8.8 7.2 4.4 0.3 34.5 20.1 2.8 33.2 34.5 0.1 1.0 9.9 0.8 0.4 0.1 39.0 0.0 3.4 1.2 0.0 0.1 0.6 0.0 0.7 0.6 0.1 0.2 0.0 0.0 0.0 4.4 27.6 0.6 0.0 5.4 0.4 0.0 0.0 20.1 0.2 7.6 7.8 0.0 0.0 1.5 3.6 0.5 1.7 62.5 7.2 0.0 96.9 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 8.9 0.4 0.4 1.0 0.1 39.0 4.9 8.3 2.8 6.1 7.1 5.3 8.9 5.6 5.8 4.4 CCDC124 ENSG00000007080 "Coiled-coil domain containing 124" Q96CT7 19 17933016-17943991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041708, HPA046765" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041708: AB_2677628, HPA046765: " "unprognostic (9.39e-2)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.68e-4)" "unprognostic (4.32e-2)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.19e-1)" "unprognostic (3.71e-2)" "unprognostic (3.22e-1)" 32.2 21.8 28.8 23.1 25.7 28.1 16.3 16.8 34.4 15.0 22.3 16.8 16.5 20.0 29.0 17.8 22.0 13.6 20.0 34.8 26.5 22.3 18.1 24.4 15.5 16.2 26.4 23.8 15.5 29.4 14.0 12.3 16.3 18.5 17.6 7.6 16.1 34.7 19.9 96.8 20.6 21.2 20.5 20.2 20.7 26.7 14.0 13.3 13.6 19.1 29.0 14.1 17.0 33.2 30.2 39.1 31.9 42.4 32.4 42.2 28.7 48.3 34.5 11.8 23.3 7.9 6.1 38.8 24.3 8.0 13.0 11.0 25.9 20.3 37.1 35.3 10.1 18.6 13.0 23.2 3.8 38.8 71.2 30.7 27.0 29.9 15.3 34.4 21.2 9.7 15.5 13.1 12.6 13.6 39.2 15.7 6.6 47.7 33.6 43.7 26.7 59.1 33.2 21.5 40.4 10.6 17.5 23.5 33.9 16.9 19.7 24.2 18.0 12.9 28.7 22.0 27.4 42.2 37.5 22.1 23.4 35.6 27.4 41.7 27.7 27.4 39.0 31.9 42.2 42.4 33.5 28.2 32.8 38.8 39.1 30.2 26.1 31.6 9.5 32.4 30.2 34.5 36.9 28.7 28.8 25.7 16.8 30.4 26.5 22.3 26.4 23.8 18.5 13.3 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA054183: " "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavourable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (9.66e-4)" "unprognostic (2.40e-2)" 23.0 20.6 12.9 21.9 14.3 27.2 14.5 23.9 15.6 12.3 18.1 12.8 16.0 17.3 16.8 16.9 10.9 12.3 14.9 23.4 13.1 13.0 14.6 11.0 15.9 16.0 11.8 11.5 20.3 18.0 24.0 26.8 18.6 13.3 11.4 16.0 14.6 13.6 24.9 20.6 16.0 18.1 17.2 15.1 17.1 12.1 15.9 12.0 17.4 17.1 10.2 20.4 11.9 19.2 4.2 3.0 6.3 5.5 3.9 5.7 2.3 13.5 6.0 16.6 14.6 24.1 16.6 14.1 16.1 10.6 10.6 10.9 13.0 8.7 11.6 11.1 12.6 11.8 9.6 8.3 13.9 15.0 9.8 14.6 10.5 17.4 10.7 15.8 16.7 11.3 8.7 16.6 19.8 11.2 8.0 8.2 11.8 5.8 10.0 17.2 7.5 9.8 12.8 13.0 7.8 8.8 14.5 13.3 7.9 10.5 8.0 11.3 6.7 9.8 15.7 18.3 15.4 15.4 11.1 10.9 11.3 18.4 10.6 11.8 10.6 6.3 4.2 4.5 5.7 5.5 5.6 4.2 4.1 4.7 3.0 4.1 5.6 4.8 4.4 3.9 3.4 1.5 1.8 2.3 12.9 14.3 23.9 15.6 13.1 13.0 11.8 11.5 13.3 12.0 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138870-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000112, CAB000316, HPA005785" Enhanced Enhanced "Golgi apparatus,Plasma membrane" "Secreted - unknown location" 2400000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavourable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 45.5 9.0 10.5 42.5 21.7 53.0 35.6 4.7 13.4 43.2 19.5 26.3 8.3 10.6 80.5 20.3 66.5 18.6 48.0 11.7 14.9 9.3 12.4 9.1 43.4 48.4 31.5 6.1 12.8 83.9 0.8 3.8 19.4 40.7 30.1 24.5 30.2 148.2 22.4 15.9 107.7 18.9 44.5 100.5 30.9 19.9 7.2 20.3 17.9 20.6 53.9 53.7 55.0 54.2 22.7 41.0 19.1 65.2 54.6 53.1 59.9 41.5 37.6 0.3 0.1 22.7 62.8 0.1 81.5 63.8 45.4 25.3 2.5 13.1 0.0 10.9 115.5 71.7 0.8 88.6 62.4 8.9 0.4 1.5 18.5 0.0 22.4 21.1 97.8 28.3 70.0 61.1 49.6 15.9 0.3 13.6 43.5 0.2 1.9 13.9 0.8 11.1 0.1 7.7 0.6 66.5 12.0 0.1 0.1 15.4 0.4 36.9 2.2 1.2 45.6 56.6 10.2 69.4 83.7 23.6 25.4 0.2 85.9 11.9 82.2 19.1 65.2 6.0 26.2 45.7 37.0 22.7 39.8 34.9 41.0 16.2 34.5 28.7 16.4 54.6 59.3 14.2 53.1 59.9 10.5 21.7 4.7 13.4 14.9 9.3 31.5 6.1 40.7 20.3 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: " "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 6.7 27.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 6.6 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell line enriched" "Detected in some" 5 "RH-30: 56.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in many" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: " "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.0 0.0 0.0 0.1 0.0 56.6 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 49.7 11.6 20.5 13.5 23.7 29.3 24.3 27.5 35.9 27.6 27.4 28.7 20.1 63.7 41.9 30.8 21.5 29.3 27.5 51.8 40.7 11.0 37.6 12.8 17.6 36.9 41.8 24.2 27.8 28.9 24.6 66.5 34.8 27.0 42.8 39.9 14.3 34.2 24.2 20.7 14.9 20.9 27.3 51.0 29.0 20.3 16.3 12.3 26.1 19.5 32.7 63.0 25.7 43.1 29.5 27.9 23.4 27.2 62.5 46.8 150.0 16.5 25.4 17.1 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227635 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 5.9 4.3 4.2 5.3 6.0 3.8 5.4 9.4 7.8 6.4 6.3 4.8 6.6 2.1 9.1 4.4 4.1 7.2 5.2 4.0 4.5 2.6 7.7 2.6 5.3 4.6 4.8 3.2 7.9 4.1 9.6 19.1 4.5 5.8 4.7 4.9 2.7 5.5 4.6 4.1 4.1 4.2 6.4 7.6 5.8 4.9 14.4 6.4 11.6 7.7 2.1 4.2 7.3 5.4 2.5 1.8 2.2 1.3 0.1 2.6 0.8 2.9 1.3 8.7 9.5 5.2 7.8 5.5 3.3 3.2 4.7 5.8 3.8 4.0 3.2 3.2 2.6 4.6 5.1 3.1 7.5 8.0 3.5 5.8 5.9 2.8 2.9 6.2 5.6 3.6 2.3 4.8 1.8 5.2 11.7 3.7 3.4 1.5 1.6 4.0 5.7 2.0 8.9 11.2 1.7 3.5 2.7 6.0 7.5 2.3 1.4 2.5 3.1 4.6 4.2 4.7 4.2 4.1 3.7 2.9 3.9 1.9 2.9 3.4 5.8 0.0 1.3 1.5 1.9 1.2 2.6 2.5 1.5 1.7 0.7 1.6 1.2 2.0 2.2 0.1 1.0 1.8 0.3 0.8 4.2 6.0 9.4 7.8 4.5 2.6 4.8 3.2 5.8 6.4 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661639-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038595: , HPA038596: AB_10672720, HPA038597: " "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 8.4 7.4 15.8 12.1 15.4 19.6 11.7 30.6 20.5 10.0 10.0 6.1 9.4 8.6 10.5 11.2 8.4 7.7 7.6 6.5 12.1 8.1 7.6 6.3 8.6 14.1 10.7 14.7 12.2 8.1 8.5 24.5 8.5 12.1 10.6 9.8 5.1 7.9 9.4 13.4 12.5 9.2 7.8 13.8 11.7 8.0 15.5 15.0 11.6 12.3 5.2 9.9 10.7 8.9 6.3 3.0 9.1 3.1 2.7 3.0 0.6 7.1 6.6 17.0 14.6 7.9 7.8 8.3 9.2 6.8 8.8 10.3 12.1 13.8 2.2 13.8 5.8 13.4 8.5 6.8 9.0 10.2 6.6 13.0 19.0 6.0 4.8 11.7 12.8 5.6 4.0 8.3 7.4 7.3 14.7 13.8 11.1 6.1 6.0 19.3 5.7 6.8 12.1 16.1 8.7 7.2 12.6 10.2 9.6 14.6 9.8 2.6 16.1 6.4 7.4 8.3 10.8 14.8 7.1 5.1 11.1 14.4 4.9 13.8 11.3 4.1 3.1 5.7 2.8 1.5 2.2 5.0 2.5 1.9 1.3 6.3 3.0 2.5 9.1 2.7 2.0 3.0 1.7 0.6 15.8 15.4 30.6 20.5 12.1 8.1 10.7 14.7 12.1 15.0 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell line enhanced" "Detected in many" "A549: 9.1;HeLa: 7.4;MCF7: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favourable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.1 0.9 1.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 4.5 0.0 0.0 0.0 3.4 1.0 0.9 7.4 2.2 0.0 0.7 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 6.5 1.3 0.5 0.8 4.9 2.0 0.9 1.5 0.0 0.4 6.3 1.1 1.9 3.6 0.7 3.2 0.3 1.7 1.9 1.5 4.9 0.8 1.0 2.5 1.1 0.7 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: , HPA076603: " "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.5 2.1 6.4 5.6 10.7 8.2 6.3 16.0 17.0 9.6 9.7 8.3 10.4 9.8 14.4 10.3 3.5 8.6 11.7 10.4 5.4 4.4 5.3 2.0 6.2 32.1 8.7 11.1 11.1 9.6 14.5 22.2 14.0 5.7 7.4 19.1 3.1 10.2 14.0 4.2 7.9 6.6 3.5 3.8 11.0 3.9 9.3 8.8 3.8 5.6 11.7 3.0 13.0 23.9 12.3 9.6 17.6 10.3 8.8 4.2 8.0 9.1 8.7 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Enhanced "Plasma membrane,Cytosol" 200000000 "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: , HPA070456: " "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favourable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 26.0 24.0 12.6 20.6 16.1 9.7 21.6 9.7 19.0 25.8 37.0 20.3 23.1 35.0 28.7 34.0 31.2 25.6 35.3 15.2 12.6 11.0 27.5 36.4 21.6 23.3 15.9 10.7 21.2 24.2 15.4 16.1 29.2 14.3 31.4 19.1 20.5 42.5 27.4 9.2 16.7 44.7 20.5 14.8 34.7 29.8 13.9 16.5 16.1 31.6 23.3 20.0 25.8 20.8 4.2 17.5 10.9 47.1 2.4 12.3 11.7 18.9 18.6 9.0 18.4 23.4 20.4 13.5 13.4 28.5 23.1 17.5 31.1 28.1 0.6 28.1 19.0 16.4 10.1 17.9 4.1 4.3 8.8 13.3 12.2 13.3 37.3 0.2 28.7 27.6 16.0 19.5 9.0 29.1 9.8 2.0 13.1 54.0 2.9 1.5 11.6 17.6 2.6 9.4 3.3 15.5 23.7 10.2 12.7 12.7 34.6 41.7 43.3 15.2 23.0 15.8 11.4 21.3 8.3 0.3 0.6 3.0 25.4 1.8 15.9 10.9 22.9 1.7 1.9 47.1 1.4 4.2 9.3 3.0 17.5 1.4 5.3 2.3 10.9 2.4 45.8 13.5 12.3 11.7 12.6 16.1 9.7 19.0 12.6 11.0 15.9 10.7 14.3 16.5 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Group enriched" "Detected in some" 5 "ASC diff: 230.1;fHDF/TERT166: 75.0" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: " "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.3 230.1 10.1 1.6 6.4 0.2 0.1 0.2 0.1 0.0 0.0 3.8 75.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 1.9 0.0 0.0 8.1 1.0 0.0 0.5 0.0 0.5 0.2 18.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.8 3.4 0.5 0.0 0.1 29.8 10.7 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 266.5" "Cell line enhanced" "Detected in all" "MCF7: 222.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" 13000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: " "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 71.2 31.4 33.5 25.8 33.2 37.9 42.1 29.6 35.4 39.0 64.7 29.6 35.9 29.5 46.4 38.9 58.8 30.3 29.4 64.2 33.2 31.7 37.4 39.5 34.2 31.4 41.6 31.4 43.9 37.2 50.3 38.4 38.8 44.4 52.6 32.9 32.0 43.2 42.0 266.5 33.8 46.5 88.3 42.4 32.2 39.9 41.5 35.1 39.6 55.7 73.9 31.9 75.4 45.5 43.9 59.0 57.9 65.2 48.1 62.3 80.5 60.6 21.4 38.1 38.0 43.5 56.6 53.3 53.6 40.1 36.1 29.4 31.3 18.4 47.8 45.3 51.1 25.8 42.2 41.6 52.7 58.4 28.8 46.9 39.0 27.7 38.5 34.8 28.0 41.0 45.3 43.2 57.1 41.3 47.5 31.4 44.1 222.4 46.7 22.2 72.6 28.9 35.0 118.0 22.5 28.7 47.8 47.1 31.3 52.5 43.8 40.6 22.5 55.7 49.7 42.7 58.9 56.0 58.8 48.0 52.2 53.6 55.2 39.6 130.2 46.4 57.7 57.9 40.9 60.8 55.5 43.9 52.2 49.7 59.0 34.7 62.3 52.3 40.9 48.1 65.2 23.0 56.7 80.5 33.5 33.2 29.6 35.4 33.2 31.7 41.6 31.4 44.4 35.1 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 19.7;SK-MEL-30: 44.8;U-138 MG: 28.9;WM-115: 42.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: " "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.5 0.0 0.3 2.2 0.5 3.1 0.0 19.7 8.8 13.8 9.0 0.0 13.7 0.0 0.4 13.7 0.1 0.0 0.1 4.3 0.1 0.0 0.0 5.7 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 44.8 0.3 0.3 0.0 28.9 5.7 1.1 0.2 0.0 0.0 0.0 6.3 0.1 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 CTNNA1 CAP102 ENSG00000044115 "Catenin alpha 1" P35221 5 138610967-138935034 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021089, HPA046119, HPA063535" Approved Enhanced "Plasma membrane,Cell Junctions" 5400 "Plasma membrane, Cell Junctions" "CAB021089: AB_10123543, HPA046119: , HPA063535: " "unprognostic (2.25e-3)" "unprognostic (3.32e-2)" "unprognostic (2.82e-3)" "unprognostic (1.80e-1)" "unprognostic (8.40e-2)" "unprognostic (2.35e-1)" "unprognostic (1.66e-3)" "unprognostic (4.83e-2)" "unprognostic (2.28e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (6.18e-2)" "prognostic favourable (7.34e-7)" "unprognostic (1.54e-1)" "unprognostic (2.31e-1)" "unprognostic (7.62e-2)" "unprognostic (1.04e-1)" 55.9 54.0 39.6 24.4 50.2 10.9 55.1 16.5 39.5 43.4 58.9 68.5 33.9 44.2 53.0 47.5 76.9 45.8 41.1 68.6 38.8 32.3 62.2 37.7 49.8 27.0 57.3 29.3 42.7 38.1 55.5 25.6 54.0 45.5 39.4 49.0 35.6 48.8 43.5 30.5 49.8 53.9 59.6 49.7 30.9 48.2 18.7 56.6 8.1 51.2 46.4 44.1 48.4 45.1 3.8 15.2 9.8 21.8 0.3 5.0 7.1 32.5 23.8 36.0 53.3 31.4 34.5 54.9 33.0 41.6 31.6 40.1 49.5 44.3 0.1 28.0 49.2 25.0 24.7 54.3 36.8 18.7 21.5 13.7 39.1 30.0 37.9 0.2 13.4 21.7 43.5 37.7 41.5 59.5 7.5 14.2 34.0 28.8 0.3 4.2 14.5 0.5 12.9 21.0 19.6 66.7 43.6 14.4 19.0 60.9 85.7 49.8 30.3 9.4 50.4 33.3 18.0 20.6 22.8 5.1 9.6 1.9 31.7 5.9 42.9 2.2 17.1 1.5 2.9 21.8 1.9 3.8 2.1 2.1 15.2 3.2 0.1 1.1 9.8 0.3 20.2 3.7 5.0 7.1 39.6 50.2 16.5 39.5 38.8 32.3 57.3 29.3 45.5 56.6 CTNNB1 "armadillo, beta-catenin, CTNNB" ENSG00000168036 "Catenin beta 1" P35222 3 41194741-41260096 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000108, CAB001950, HPA029159, HPA029160" Supported Enhanced "Plasma membrane" 1000000 "Plasma membrane" "CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996" "unprognostic (2.47e-1)" "unprognostic (3.48e-2)" "prognostic favourable (7.54e-4)" "unprognostic (1.61e-1)" "unprognostic (9.55e-2)" "unprognostic (1.05e-2)" "unprognostic (3.20e-3)" "unprognostic (2.79e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-2)" "unprognostic (1.88e-2)" "unprognostic (9.05e-2)" "unprognostic (1.97e-3)" "unprognostic (1.82e-2)" "unprognostic (1.17e-1)" "unprognostic (2.61e-1)" "unprognostic (9.79e-2)" 52.9 54.5 38.8 33.5 45.9 46.3 70.5 78.8 59.3 71.7 49.6 57.3 34.2 48.7 79.2 42.5 46.3 49.8 45.0 42.1 38.6 41.5 46.9 53.2 53.6 31.6 37.0 47.0 84.2 38.6 59.2 44.0 82.6 41.5 50.8 50.1 75.9 53.9 49.7 31.2 44.7 70.4 66.5 39.4 41.0 37.3 29.0 39.3 40.1 62.3 44.5 36.6 46.9 54.2 10.1 13.5 7.5 14.5 11.1 13.5 4.8 22.6 30.2 63.7 35.6 34.4 28.2 48.9 25.6 36.4 42.8 42.5 20.8 32.4 18.6 23.4 45.2 17.0 46.1 73.9 45.9 17.2 31.4 30.0 40.1 74.3 25.7 17.0 14.4 41.0 33.5 51.1 31.1 37.6 21.2 11.6 47.4 23.0 11.9 9.2 58.0 23.5 9.0 41.5 12.4 26.5 70.9 15.2 25.8 42.4 21.6 113.7 35.4 35.4 48.4 32.2 24.7 20.6 37.5 7.2 11.2 19.8 33.0 21.5 53.7 4.3 8.1 6.9 11.2 14.5 13.5 9.6 10.5 12.1 13.5 10.1 10.7 10.8 7.5 11.1 13.7 11.7 12.6 4.8 38.8 45.9 78.8 59.3 38.6 41.5 37.0 47.0 41.5 39.3 CTNND1 "CTNND, KIAA0384, p120, p120cas, p120ctn" ENSG00000198561 "Catenin delta 1" O60716 11 57753243-57819546 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.5;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 10.2;monocytes: 12.5" "Low region specificity" "Detected in all" "CAB003837, HPA015954, HPA015955" Enhanced Enhanced "Plasma membrane" 15000 "Plasma membrane" "CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068" "unprognostic (1.06e-2)" "unprognostic (1.60e-2)" "unprognostic (5.17e-3)" "unprognostic (4.87e-2)" "unprognostic (7.81e-2)" "unprognostic (2.30e-1)" "unprognostic (2.98e-2)" "unprognostic (3.52e-3)" "unprognostic (4.17e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (2.75e-1)" "prognostic favourable (3.54e-4)" "unprognostic (7.17e-2)" "unprognostic (4.09e-2)" "unprognostic (3.34e-1)" "unprognostic (7.33e-2)" 39.7 19.9 15.1 20.4 17.0 3.2 31.4 15.0 20.5 28.8 41.9 25.7 49.2 37.5 32.7 32.7 76.3 22.9 28.8 18.2 15.6 10.3 30.6 31.2 34.0 11.6 14.4 12.8 23.3 50.4 41.9 34.5 49.8 16.4 29.7 39.8 34.4 46.4 39.1 11.8 48.7 82.0 22.8 17.2 25.9 39.4 27.8 14.7 7.1 38.4 34.9 45.6 32.3 38.9 1.4 10.2 0.4 12.5 0.4 0.5 2.3 37.4 28.1 25.1 16.8 13.6 18.6 35.6 17.2 19.4 15.6 14.9 21.8 41.6 0.7 30.4 21.3 49.2 20.2 26.1 20.0 0.4 6.6 9.3 11.0 24.6 14.1 2.0 14.7 20.5 31.6 19.7 20.2 47.4 14.0 0.4 17.2 12.1 0.7 3.5 17.9 15.1 0.7 21.2 0.8 23.3 40.0 2.3 11.2 24.3 33.3 25.4 35.0 2.5 40.1 15.0 12.9 14.7 9.7 1.3 0.8 1.1 14.0 1.2 26.4 0.0 6.9 0.2 0.2 12.5 0.5 1.0 0.1 0.4 10.2 1.4 0.2 0.3 0.4 0.4 11.9 3.1 0.2 2.3 15.1 17.0 15.0 20.5 15.6 10.3 14.4 12.8 16.4 14.7 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell line enhanced" "Detected in many" "CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favourable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.5 3.1 15.2 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.9 31.7 4.9 2.0 6.8 0.0 9.6 7.6 2.0 0.3 3.1 6.5 0.0 9.1 20.5 0.9 0.6 0.0 0.0 8.3 0.4 0.1 3.0 0.1 0.1 0.0 0.3 1.2 0.0 36.7 0.0 0.0 5.1 3.9 12.7 35.4 6.1 4.1 3.6 4.1 2.1 8.4 0.1 0.1 0.0 9.1 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 14.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.2 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 DAB2 DOC-2 ENSG00000153071 "DAB2, clathrin adaptor protein" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 194.4" "Cell line enhanced" "Detected in many" "ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "plasmacytoid DC: 26.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: " "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavourable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 51.6 44.2 2.6 12.2 3.5 0.6 21.8 6.1 2.6 16.6 14.0 4.1 4.5 3.3 16.6 34.8 10.8 9.6 13.3 25.1 2.9 3.0 75.2 6.9 22.4 31.8 4.0 2.1 12.7 11.3 3.2 3.9 194.4 4.7 11.6 14.6 14.6 12.9 5.3 12.7 9.3 10.4 16.0 5.2 21.1 7.2 8.7 2.5 7.3 10.9 8.4 7.4 17.8 14.7 0.1 26.6 2.2 2.5 0.9 1.3 7.0 0.0 1.5 2.4 5.3 42.2 45.4 3.0 27.2 27.9 10.7 17.7 19.9 0.0 0.0 1.7 65.6 0.0 0.3 0.9 15.1 0.0 0.8 3.6 36.2 6.5 10.2 0.0 4.7 28.2 0.0 17.5 3.1 32.2 0.0 0.9 17.7 0.1 0.3 0.0 1.6 3.0 0.9 6.2 0.0 7.1 0.5 0.0 0.0 3.2 1.7 15.2 0.1 0.9 39.5 46.0 5.1 5.3 2.2 0.0 0.0 0.0 16.0 3.4 5.9 2.2 1.2 0.2 1.3 2.5 0.0 0.1 0.2 0.7 3.4 0.1 0.1 1.0 1.8 0.9 0.6 26.6 0.2 7.0 2.6 3.5 6.1 2.6 2.9 3.0 4.0 2.1 4.7 2.5 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.5;LHCN-M2: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.7 3.5 2.0 15.0 28.0 1.6 27.2 6.9 12.1 13.7 0.9 1.8 2.0 4.6 12.9 2.1 4.4 2.4 20.7 2.3 1.2 1.0 8.2 6.6 20.3 0.5 0.5 11.6 6.6 15.7 4.5 42.5 4.4 1.4 72.3 0.1 0.6 1.5 2.1 1.3 1.1 6.0 1.3 2.9 0.7 2.5 0.8 3.1 2.3 2.6 0.9 0.8 20.3 17.1 4.2 12.1 3.5 1.2 0.4 1.8 2.3 1.2 2.9 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Cell line enhanced" "Detected in some" "HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Not detected" "Not detected" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: , HPA073937: " "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavourable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.4 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.4 0.0 16.0 0.0 0.0 3.8 0.2 1.3 0.1 2.6 0.0 0.0 2.7 41.1 0.0 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 EEF2 "EEF-2, EF2" ENSG00000167658 "Eukaryotic translation elongation factor 2" P13639 19 3976056-3985469 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007795, HPA040534, HPA057351" Enhanced Enhanced "Plasma membrane,Cytosol" 9700000 "Plasma membrane, Cytosol" "CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417" "unprognostic (5.47e-2)" "unprognostic (9.59e-2)" "unprognostic (3.75e-1)" "prognostic favourable (1.81e-6)" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.11e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.42e-1)" "prognostic favourable (1.25e-5)" "unprognostic (4.46e-2)" "unprognostic (5.60e-2)" "unprognostic (6.82e-2)" "unprognostic (9.86e-2)" 104.2 84.9 64.0 66.7 57.1 92.7 77.5 55.7 96.2 93.4 91.3 55.8 80.8 95.4 100.1 75.1 115.1 83.4 88.6 104.1 51.6 44.4 65.5 161.0 67.7 108.9 51.4 38.3 167.1 395.7 45.1 72.3 63.7 47.5 105.6 41.3 67.7 191.3 64.4 260.8 87.2 100.9 112.3 46.8 85.4 98.5 70.9 32.4 123.4 127.1 112.5 108.3 111.8 94.7 84.9 60.0 10.0 58.4 48.3 76.3 83.7 95.2 68.4 39.8 105.1 106.7 192.3 57.3 74.9 101.4 71.7 70.6 107.8 44.2 199.0 44.6 69.1 72.3 62.8 116.0 38.0 49.6 104.2 50.8 65.7 110.7 156.0 109.1 88.4 248.2 122.7 63.1 97.7 74.2 99.1 146.7 43.6 138.2 97.9 83.7 105.3 69.2 109.1 59.2 126.5 59.0 85.2 109.0 101.3 47.1 94.3 135.0 91.9 132.7 88.9 51.4 53.7 104.4 115.2 157.4 105.6 99.0 76.6 137.2 67.0 10.0 58.4 8.3 38.6 45.8 68.7 84.9 67.7 50.8 60.0 70.7 76.3 59.4 6.1 48.3 43.8 50.5 58.4 83.7 64.0 57.1 55.7 96.2 51.6 44.4 51.4 38.3 47.5 32.4 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell line enriched" "Detected in many" 12 "A-431: 337.7" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavourable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 337.7 4.3 1.1 1.5 6.9 4.3 1.1 3.3 4.5 2.0 1.6 0.8 3.7 0.2 0.8 2.8 13.5 0.0 14.9 2.5 0.1 0.2 0.0 1.8 0.2 1.8 0.0 0.0 2.1 13.7 5.2 27.9 0.2 0.0 0.0 4.4 0.2 0.0 0.0 0.3 2.2 0.0 0.6 0.0 2.5 3.6 0.0 1.3 2.8 3.4 0.6 0.3 0.7 1.0 1.9 0.5 14.6 3.1 0.0 0.3 0.1 2.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 EHBP1 "KIAA0903, NACSIN" ENSG00000115504 "EH domain binding protein 1" Q8NDI1 2 62673851-63046487 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035468, HPA035469" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA035468: AB_10671513, HPA035469: AB_10601365" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (8.78e-2)" "unprognostic (3.83e-3)" "unprognostic (1.43e-1)" "unprognostic (1.57e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.78e-1)" "unprognostic (1.95e-1)" "unprognostic (3.33e-2)" "unprognostic (3.14e-1)" "unprognostic (3.13e-3)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-2)" "prognostic unfavourable (1.95e-8)" 19.6 12.6 19.8 10.2 15.4 4.0 12.0 27.5 22.5 22.5 22.3 8.0 7.5 6.8 22.3 6.0 20.9 12.7 18.2 7.8 16.0 15.9 12.3 36.9 8.1 5.7 17.1 13.0 35.1 10.9 9.7 14.5 8.2 12.8 12.6 10.4 8.6 10.2 14.0 5.4 7.4 8.5 21.4 9.3 5.4 11.1 24.1 9.8 5.4 10.4 7.5 7.0 12.3 12.7 8.4 5.4 3.5 3.6 4.7 6.8 2.8 18.3 25.4 10.4 6.2 18.2 35.2 10.5 16.4 16.1 12.1 10.0 30.2 13.8 12.7 6.0 30.0 11.2 13.4 11.6 20.1 13.5 6.3 10.9 9.0 35.6 12.5 6.3 8.4 16.2 21.0 12.3 24.1 7.7 7.5 7.3 19.4 7.1 7.3 4.0 10.1 9.9 6.6 13.0 5.4 8.1 6.0 11.3 9.2 13.5 10.0 16.3 4.8 6.3 5.6 13.1 13.6 21.5 8.6 8.4 5.7 12.1 13.0 9.9 26.1 0.2 3.4 3.5 6.3 3.6 6.3 8.4 6.8 6.0 5.4 7.3 6.7 5.7 1.3 4.7 1.9 3.5 3.7 2.8 19.8 15.4 27.5 22.5 16.0 15.9 17.1 13.0 12.8 9.8 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000867, CAB004226" Supported Enhanced "Plasma membrane,Cytosol" 21000 Cytosol "Plasma membrane" "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favourable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 35.7 31.9 36.5 20.8 41.1 67.7 34.4 31.5 47.2 21.3 32.5 25.5 18.8 31.7 27.6 23.5 34.0 27.6 26.2 34.1 37.9 34.2 37.9 78.4 27.3 37.2 37.1 33.3 24.7 32.1 30.1 26.7 31.9 39.3 23.4 32.5 19.2 28.5 32.8 59.4 22.7 31.5 39.5 36.9 31.1 28.2 39.1 27.0 29.6 40.1 30.5 31.1 29.1 37.9 96.7 96.6 90.1 74.3 86.8 90.5 102.2 21.4 25.2 29.3 13.3 25.5 22.6 31.0 31.7 34.4 32.7 24.9 37.1 22.9 22.3 20.1 28.4 28.9 36.9 32.1 55.9 18.2 14.7 19.9 13.3 19.5 26.6 35.8 17.1 24.2 21.6 28.9 39.6 32.8 41.1 21.4 27.0 30.8 24.4 11.9 15.3 48.1 20.7 38.2 13.9 19.3 70.0 26.2 18.4 31.7 23.8 25.7 22.8 16.5 24.9 26.2 17.9 33.4 33.0 64.1 123.4 46.8 25.8 25.2 30.5 83.4 74.3 90.1 74.1 73.2 82.6 95.9 76.0 69.3 70.7 96.7 90.5 76.1 80.3 86.8 73.8 96.6 62.3 102.2 36.5 41.1 31.5 47.2 37.9 34.2 37.1 33.3 39.3 27.0 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH, actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" 18000 "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 19.2 17.4 15.8 11.9 17.0 0.6 11.1 7.6 17.6 17.8 24.4 15.3 39.9 9.3 21.9 19.9 16.7 11.8 29.0 18.2 16.7 15.3 5.8 5.9 13.8 3.5 13.7 11.3 24.3 16.7 22.5 10.3 13.5 12.7 26.4 8.0 3.3 14.5 44.9 20.2 8.2 8.0 61.4 13.4 17.3 21.0 18.5 17.2 5.3 6.8 11.4 3.5 35.3 21.9 2.1 0.4 1.0 0.3 0.5 0.4 0.0 20.2 16.2 20.1 18.2 7.9 10.4 26.0 22.5 10.8 13.6 10.3 10.4 7.5 8.6 60.0 34.7 17.9 23.5 8.5 12.9 0.1 14.5 8.9 14.4 14.0 23.6 1.0 0.3 16.1 10.3 17.6 22.6 10.7 0.6 0.4 13.4 3.9 4.0 1.0 33.9 14.7 6.1 28.5 0.2 6.2 15.7 19.8 16.0 44.2 16.9 14.9 20.1 1.3 20.8 35.3 26.0 29.3 44.6 0.9 2.5 5.8 19.4 1.1 18.0 1.0 0.3 0.2 0.4 0.1 0.3 0.6 0.4 0.3 0.0 2.1 0.4 0.4 1.0 0.5 0.2 0.4 0.2 0.0 15.8 17.0 7.6 13.7 16.7 15.3 13.7 11.3 12.7 17.2 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879250 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394" Supported Enhanced "Plasma membrane,Cytosol" 490000000 "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: " "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavourable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 68.6 57.7 92.7 94.9 109.6 121.8 73.4 46.6 119.4 47.3 63.8 74.6 21.7 71.3 44.9 24.2 138.2 52.2 55.0 45.2 79.1 70.7 180.4 165.4 64.8 80.3 74.9 62.7 58.2 31.6 52.7 35.5 70.5 88.6 38.6 66.4 62.6 106.1 69.1 45.0 74.6 70.3 84.0 56.4 80.0 44.3 31.7 48.8 98.8 55.4 91.0 119.3 73.5 62.9 38.7 114.1 22.1 105.4 55.5 63.7 159.3 180.7 158.0 76.2 65.2 63.8 71.3 69.1 98.3 109.0 211.8 199.1 101.1 105.0 130.3 131.2 118.2 89.2 129.4 262.3 216.0 88.9 136.7 110.0 160.5 125.6 95.9 219.2 67.8 73.6 79.6 167.7 255.0 135.6 120.5 51.0 137.3 89.5 82.6 117.4 83.1 158.6 85.6 113.6 212.8 250.7 43.1 103.1 63.7 115.3 167.9 121.2 84.1 65.7 123.9 146.7 129.9 125.1 167.1 145.5 103.2 197.7 227.8 179.8 123.1 13.9 105.4 20.8 52.3 75.8 59.1 38.7 55.8 53.8 114.1 32.7 45.6 47.8 22.1 55.5 72.4 31.2 63.7 159.3 92.7 109.6 46.6 119.4 79.1 70.7 74.9 62.7 88.6 48.8 EPB41L2 4.1-G ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" 170000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavourable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 50.2 16.5 29.6 17.3 42.8 3.9 21.1 6.5 40.1 20.5 23.1 32.3 7.2 12.3 23.0 13.7 13.2 25.6 18.0 22.8 33.4 24.6 11.5 12.1 24.4 15.4 50.5 33.1 44.4 9.1 8.2 8.4 26.2 34.8 11.2 23.2 52.0 10.1 15.8 16.0 7.1 21.4 20.6 59.5 25.3 11.7 32.2 51.9 6.8 15.2 14.6 11.6 15.2 16.6 10.5 8.6 0.5 8.8 1.0 2.5 1.3 8.3 8.7 19.8 27.2 13.8 22.1 6.1 14.1 17.8 14.4 20.1 16.6 11.8 10.1 26.5 19.3 4.3 7.6 13.0 28.8 43.0 17.5 18.1 10.4 9.5 8.1 0.0 22.2 10.8 0.2 25.4 9.8 22.1 49.1 29.1 9.1 2.1 14.1 3.1 18.3 9.5 22.1 23.8 0.9 24.2 7.9 2.1 0.0 5.9 0.1 11.4 3.0 18.9 26.7 17.0 32.0 28.6 42.3 24.1 0.4 9.5 11.6 0.1 25.8 0.1 3.1 0.5 1.0 8.8 0.9 2.9 1.0 1.2 8.6 10.5 1.7 0.7 0.0 1.0 3.3 2.3 2.5 1.3 29.6 42.8 6.5 39.6 33.4 24.6 50.5 33.1 34.8 51.9 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.0 0.3 1.2 0.0 17.6 20.5 13.8 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 12.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 1.4 10.7 0.0 3.8 0.0 18.5 0.1 0.1 0.0 0.0 0.1 0.2 2.5 3.9 0.0 0.0 0.0 0.1 1.4 20.7 0.1 0.0 0.1 8.2 0.2 1.4 50.8 0.1 18.5 18.0 21.8 0.0 0.0 0.0 0.0 1.6 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 EPB41L5 "BE37, FLJ12957, KIAA1548, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013005-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 24.8;MCF7: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favourable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 4.6 5.0 7.4 6.0 11.6 1.1 13.3 19.4 12.6 7.4 8.6 6.9 4.3 10.6 7.2 4.9 7.0 10.2 6.2 4.9 8.5 7.4 25.6 42.3 36.3 3.8 7.6 6.5 9.4 20.3 13.0 15.8 7.5 12.2 9.9 7.0 7.1 10.8 6.6 8.6 6.6 9.5 7.5 14.8 2.2 7.0 22.0 6.1 2.9 25.2 6.4 5.0 5.3 8.4 4.7 0.4 1.8 1.4 1.5 3.2 1.4 7.9 2.7 11.0 8.5 7.7 5.6 9.6 1.7 1.7 3.6 3.2 24.8 5.3 0.1 6.0 2.1 5.5 14.8 6.8 5.4 1.6 4.6 2.3 1.3 13.8 9.0 1.0 2.5 5.0 12.8 6.7 4.8 10.1 5.4 0.6 7.1 37.1 1.8 3.5 9.9 2.5 0.0 3.3 2.2 11.3 7.7 5.7 10.9 7.5 13.4 3.7 6.4 1.9 8.3 0.3 5.3 5.7 1.7 0.8 1.5 4.1 0.9 0.0 2.0 0.3 1.4 1.5 1.1 0.3 0.3 4.7 1.2 1.1 0.4 3.6 3.2 2.4 1.8 1.5 0.9 0.0 0.5 1.4 7.4 11.6 19.4 12.6 8.5 7.4 7.6 6.5 12.2 6.1 EZR VIL2 ENSG00000092820 Ezrin P15311 6 158765741-158819412 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004035, HPA021616, CAB047324, CAB075739" Enhanced Enhanced "Plasma membrane" 75000000 "Plasma membrane" "CAB004035: AB_2100309, CAB047324: , CAB075739: , HPA021616: AB_1848342" "unprognostic (4.79e-3)" "unprognostic (1.48e-1)" "unprognostic (1.97e-2)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.31e-3)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" "unprognostic (7.53e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (5.59e-2)" "prognostic favourable (9.56e-8)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-2)" "unprognostic (9.00e-2)" 22.8 56.4 30.9 31.2 31.4 24.7 13.3 4.0 21.5 18.0 45.5 28.2 35.2 33.8 9.8 25.8 71.8 25.1 30.2 34.3 37.6 13.9 53.5 16.2 44.3 36.7 14.8 19.0 20.7 33.0 77.1 14.6 125.1 23.5 21.7 22.8 37.0 27.4 32.0 13.6 47.5 87.9 22.8 12.8 26.0 55.4 21.4 22.2 41.6 37.1 34.4 75.6 38.2 25.3 81.7 30.0 24.3 31.2 20.7 61.7 41.1 87.0 47.6 11.8 16.9 1.3 1.4 68.9 27.4 9.0 30.9 26.1 55.7 48.3 87.7 27.2 31.3 66.8 23.2 30.5 35.9 30.6 15.0 1.8 28.9 24.6 31.4 21.7 13.5 2.3 23.7 29.1 28.3 20.2 17.3 43.0 17.9 22.9 30.7 26.2 19.6 15.9 23.1 5.5 19.9 63.5 26.5 21.4 17.5 47.9 69.1 5.2 16.8 28.7 26.1 10.0 32.1 13.7 42.1 29.7 27.0 75.2 6.2 11.2 11.9 24.3 14.0 16.4 34.8 31.2 41.0 81.7 36.7 42.9 30.0 67.5 19.9 26.5 6.1 20.7 30.6 14.0 61.7 41.1 30.9 31.4 4.0 21.5 37.6 13.9 14.8 19.0 23.5 22.2 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 7 "HEL: 24.3;HMC-1: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favourable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.0 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.6 0.1 0.2 0.2 0.3 0.3 24.3 0.9 0.4 0.2 0.3 9.8 0.0 0.1 0.3 0.2 0.8 1.9 1.0 0.1 0.3 0.3 2.4 0.3 0.2 0.2 0.2 0.7 0.2 0.5 0.4 0.2 0.2 0.1 0.1 0.5 1.6 0.9 0.5 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.5 30.3 24.0 44.0 40.9 24.3 15.1 8.0 24.5 0.0 17.5 49.7 36.9 4.4 32.6 8.0 4.2 4.7 3.7 37.5 8.3 30.7 0.1 10.8 33.2 20.5 40.0 14.1 36.6 7.1 0.2 46.1 26.1 0.2 6.2 5.3 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 35.9 25.6 15.6 16.8 1.2 47.3 25.0 10.9 31.4 36.3 0.4 0.8 0.0 70.5 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell line enhanced" "Detected in many" "SK-BR-3: 152.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavourable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.1 24.3 11.3 7.8 18.3 12.4 24.2 4.6 6.0 4.9 9.0 25.4 15.8 7.7 3.8 3.5 19.4 10.9 21.3 0.9 3.6 47.4 16.0 18.2 33.9 5.2 8.6 2.4 11.9 5.6 12.5 2.9 5.5 24.1 6.9 1.7 40.1 9.4 13.7 21.9 14.2 8.3 6.4 15.3 5.5 29.7 28.1 15.6 6.8 152.8 12.4 27.2 16.5 9.6 7.2 14.8 5.9 11.0 9.3 2.0 8.0 4.3 9.4 10.6 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374638 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 396.7;urinary bladder: 276.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" 2900000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavourable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (3.88e-4)" 42.8 8.8 2.9 46.4 3.9 22.9 30.7 2.0 5.2 106.5 204.2 6.3 86.0 13.1 158.9 54.4 140.2 79.9 121.0 18.8 3.2 2.2 17.2 5.5 29.1 21.1 3.4 5.9 77.4 7.3 1.6 4.8 20.0 9.4 129.3 13.4 19.0 12.6 98.8 13.7 15.0 50.2 396.7 3.6 25.5 82.7 29.9 2.9 12.1 11.7 16.3 15.1 276.1 64.5 6.3 13.1 7.1 19.7 5.9 22.6 24.1 87.2 67.8 23.9 30.8 20.9 27.7 39.4 58.4 65.1 53.6 47.7 43.9 16.2 7.5 151.6 90.7 50.1 21.5 51.2 15.1 30.8 7.5 24.2 88.7 15.2 38.5 28.6 31.8 26.5 12.4 79.8 31.9 39.8 6.8 52.3 38.3 20.0 13.6 9.9 25.2 45.1 13.7 21.7 6.7 20.8 18.2 5.3 12.1 48.8 7.9 39.3 7.6 9.0 95.2 61.2 59.0 62.0 107.6 32.8 19.2 15.2 56.9 19.2 61.2 4.1 11.5 7.1 22.6 15.2 14.3 6.3 10.5 18.7 13.1 3.0 4.0 9.1 2.6 5.9 19.7 1.7 12.8 24.1 2.9 3.9 2.0 5.2 3.2 2.2 3.4 5.9 9.4 2.9 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "NK-cells: 15.3;T-cells: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" 2000000 "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: " "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favourable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favourable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 29.1 7.2 49.2 29.0 38.4 16.3 18.1 33.9 62.1 25.7 12.1 33.7 4.1 10.1 21.8 21.4 10.2 32.0 19.4 21.2 39.4 34.0 9.5 12.2 25.2 57.2 35.7 23.1 18.6 4.4 15.0 12.5 17.7 25.6 9.6 10.0 11.0 6.4 8.4 7.0 16.5 19.0 24.2 30.9 39.8 15.4 10.1 31.3 34.8 27.5 5.6 38.5 22.6 19.3 1.6 1.7 0.7 1.5 15.3 43.2 10.7 1.9 0.2 34.2 5.7 26.2 16.1 0.6 5.4 17.1 4.6 8.3 0.2 0.3 3.8 3.5 10.4 0.2 4.8 7.5 9.1 0.1 12.6 10.5 2.5 0.5 15.5 3.5 3.6 15.4 11.3 17.4 14.9 18.8 0.8 26.8 16.4 0.2 16.7 3.2 4.9 3.4 5.3 4.6 0.2 0.0 1.7 24.0 9.7 1.0 0.4 22.8 0.2 10.6 11.9 14.0 2.6 103.1 3.4 3.8 3.5 5.9 26.4 8.2 24.3 0.2 1.5 0.0 34.1 1.2 43.2 1.1 21.2 37.5 1.7 1.6 7.0 18.7 0.7 15.3 0.9 1.0 17.6 10.7 49.2 38.4 33.9 35.3 39.4 34.0 35.7 23.1 25.6 31.3 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell line enhanced" "Detected in some" "AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 22.4 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 GAPVD1 "DKFZP434C212, KIAA1521" ENSG00000165219 "GTPase activating protein and VPS9 domains 1" Q14C86 9 125261794-125367207 "Predicted intracellular proteins" Endocytosis "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029386, HPA029387" Uncertain Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA029386: AB_10599604, HPA029387: AB_10600311" "unprognostic (8.43e-3)" "unprognostic (3.84e-2)" "unprognostic (3.53e-1)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (4.04e-2)" "unprognostic (7.08e-2)" "unprognostic (1.31e-2)" "unprognostic (7.56e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "unprognostic (2.54e-3)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (1.67e-2)" "unprognostic (5.82e-2)" 17.6 16.2 16.0 14.9 18.6 26.6 16.9 25.7 21.3 17.5 16.1 20.9 18.0 10.8 19.1 14.0 24.3 16.0 13.7 15.4 15.5 14.1 17.6 14.5 20.5 15.1 21.1 15.6 18.9 14.1 30.3 20.2 23.3 20.1 14.7 13.2 16.4 15.9 17.2 31.6 23.5 14.6 17.4 15.3 17.3 14.6 32.1 20.2 18.6 24.8 12.2 19.9 16.2 17.7 10.4 14.8 19.2 17.8 13.6 14.8 10.0 11.5 12.0 11.4 10.6 13.8 15.1 16.6 12.9 14.8 15.0 12.6 19.1 8.3 15.4 7.0 16.2 23.5 23.6 13.5 16.0 14.1 14.1 17.5 29.5 9.4 16.3 20.8 29.6 10.8 13.2 17.8 14.4 17.8 33.9 8.5 12.5 16.9 15.5 9.1 11.5 13.7 13.6 24.9 14.9 8.6 11.9 15.2 10.2 18.8 17.4 10.3 21.4 10.8 18.6 10.6 7.8 18.9 13.8 11.0 20.7 15.8 13.0 11.8 13.6 18.6 15.0 18.0 13.7 15.6 13.4 10.2 14.2 14.8 14.8 10.4 14.2 14.7 19.2 13.6 17.8 5.6 10.9 10.0 16.0 18.6 25.7 21.3 15.5 14.1 21.1 15.6 20.1 20.2 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell line enhanced" "Detected in many" "A-431: 41.8;CAPAN-2: 161.0;HaCaT: 42.2;SiHa: 59.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: " "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavourable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 41.8 33.5 0.0 0.1 0.4 0.2 2.1 12.6 4.8 8.2 6.3 5.8 161.0 0.0 1.0 10.0 42.2 0.1 6.1 12.6 0.0 0.5 0.0 13.8 0.2 3.0 0.0 0.0 0.2 8.2 3.4 0.8 5.0 0.0 0.0 0.3 29.3 0.0 0.0 0.1 5.2 0.0 0.9 0.0 16.3 8.3 0.0 0.0 59.2 4.5 1.9 1.3 0.1 0.5 0.3 10.7 19.2 0.5 0.0 0.0 0.0 4.3 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: " "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 3.3 5.9 6.3 3.3 13.9 7.5 3.7 2.6 8.5 3.8 4.4 11.8 5.4 4.0 3.6 5.4 4.4 3.3 3.7 3.7 6.0 4.4 4.6 4.9 3.2 4.6 16.6 4.2 2.6 4.8 5.4 8.3 5.9 9.2 3.6 5.3 3.4 4.5 3.0 4.9 5.0 4.1 4.5 7.7 4.3 6.2 19.2 13.0 4.8 4.1 0.6 5.0 4.4 3.1 6.7 8.2 20.3 10.2 6.0 10.1 4.5 3.7 6.1 5.1 4.8 10.1 6.2 6.0 5.4 5.2 7.5 9.4 4.2 4.3 6.5 3.5 4.4 7.3 5.4 4.7 7.0 7.6 6.4 6.6 4.7 4.7 11.7 6.1 9.0 7.7 12.7 4.9 9.7 4.6 10.3 8.2 6.1 7.9 7.5 2.6 13.7 7.4 5.1 7.1 11.5 5.8 4.4 4.8 4.0 6.4 6.9 7.7 11.5 5.4 4.4 7.5 5.8 9.8 4.8 7.8 8.3 7.0 5.7 3.7 7.6 20.3 7.5 10.2 10.1 10.2 7.1 5.0 8.3 7.5 6.2 6.7 8.1 8.9 11.1 6.0 9.2 8.2 9.8 4.5 6.3 13.9 2.6 8.5 6.0 4.4 16.6 4.2 9.2 13.0 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302544-76304295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 565.5" "Cell line enhanced" "Detected in many" "hTCEpi: 162.0;MCF7: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" 57000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavourable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 67.6 41.7 23.0 42.9 22.8 7.3 186.2 10.1 21.3 127.6 84.9 10.8 89.2 27.1 126.5 65.9 410.5 57.7 52.2 164.8 21.4 22.5 85.4 26.3 43.3 25.1 25.7 14.3 63.4 34.7 16.6 15.5 106.9 32.8 99.6 12.0 31.1 50.5 101.3 439.2 164.4 24.6 139.7 27.3 17.8 37.6 22.0 23.4 31.9 72.9 207.3 126.8 146.2 565.5 27.8 17.8 4.1 27.9 23.2 36.8 14.4 72.6 54.0 5.8 43.1 35.1 31.1 0.3 30.9 16.3 16.8 21.1 4.8 42.6 0.6 23.9 40.0 66.7 25.3 18.1 5.4 40.5 8.5 3.3 41.7 22.8 18.8 4.9 30.5 38.6 162.0 25.3 3.7 55.4 26.4 74.3 19.2 227.6 8.3 33.6 29.6 47.3 25.7 11.9 59.0 24.9 27.7 0.4 33.1 21.7 88.6 27.6 104.4 34.8 29.9 50.5 75.3 15.7 77.9 5.2 8.6 0.7 36.9 15.2 36.7 4.1 4.5 2.8 18.6 21.1 9.6 27.5 30.6 20.2 11.1 27.8 36.8 31.5 1.7 23.2 27.9 17.8 19.7 14.4 23.0 22.8 10.1 21.3 21.4 22.5 25.7 14.3 32.8 23.4 JPT2 "C16orf34, FLJ13092, HN1L, KIAA1426, L11" ENSG00000206053 "Jupiter microtubule associated homolog 2" Q9H910 16 1678256-1702280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041888, HPA041908" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041888: AB_10793937, HPA041908: AB_10794160" "unprognostic (1.49e-2)" "unprognostic (1.76e-1)" "unprognostic (1.30e-3)" "prognostic favourable (7.85e-4)" "unprognostic (3.60e-1)" "unprognostic (2.37e-2)" "prognostic unfavourable (9.14e-4)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (1.50e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (1.01e-2)" "unprognostic (9.22e-3)" "unprognostic (1.65e-1)" "unprognostic (4.14e-2)" "unprognostic (2.78e-2)" 10.6 11.3 6.7 10.4 24.3 4.9 19.9 11.1 12.3 22.5 16.7 24.1 12.6 11.3 11.5 11.1 28.6 34.4 12.4 10.1 10.5 8.7 18.5 37.3 12.0 11.7 33.8 6.2 12.3 31.0 13.2 10.1 33.6 37.7 26.3 16.5 6.8 15.7 12.7 12.8 16.2 12.8 12.4 72.4 8.7 14.8 14.1 17.3 20.3 16.1 15.7 16.8 16.9 16.8 9.7 8.2 4.7 4.6 7.5 10.0 5.4 31.2 32.1 37.3 20.7 5.4 9.0 33.8 31.1 9.9 26.3 22.5 41.8 41.1 20.3 24.0 15.4 30.8 49.0 42.3 30.3 16.3 29.5 16.7 18.4 23.7 8.3 19.6 10.0 6.3 26.8 25.8 33.6 16.6 39.2 8.2 15.1 36.2 24.4 9.7 40.9 24.4 45.1 35.3 29.2 41.0 17.7 34.8 19.2 46.8 45.4 14.2 55.0 12.7 19.1 25.6 45.1 12.1 30.3 7.0 27.9 42.3 8.0 15.2 37.3 2.6 4.6 4.7 7.1 4.1 10.0 6.3 7.8 5.6 3.6 9.7 8.5 7.1 0.4 7.5 2.0 8.2 7.0 5.4 6.7 24.3 11.1 12.3 10.5 8.7 33.8 6.2 37.7 17.3 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB022079: , HPA058432: " "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favourable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.8 7.5 10.5 4.5 2.0 1.0 8.4 1.4 0.7 1.9 1.3 13.5 7.3 0.0 4.7 0.6 5.1 6.0 3.6 1.8 11.4 4.8 0.0 13.1 12.3 1.5 9.7 0.0 0.6 8.1 2.4 11.8 2.5 11.0 12.1 1.5 3.5 1.2 0.0 14.1 6.5 0.0 0.0 6.7 7.4 9.7 14.4 62.6 5.7 9.1 3.4 10.5 1.2 1.7 1.1 4.6 0.3 4.1 5.5 1.8 0.0 2.7 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.2 24.8 12.1 7.2 7.3 5.9 9.4 14.3 10.3 14.7 11.4 13.5 6.1 9.1 13.8 10.6 17.1 12.4 13.9 4.9 14.6 15.6 1.8 19.6 9.1 14.2 4.0 9.7 5.9 18.4 17.2 14.1 6.8 9.8 12.4 11.7 28.5 22.9 6.1 11.9 20.6 8.8 6.3 12.4 11.5 11.4 33.0 16.0 10.4 9.4 17.1 15.5 2.8 11.2 24.2 21.7 29.2 18.8 12.9 10.8 4.9 17.1 2.8 9.7 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 3.7 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 31.7 12.1 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 LIMA1 EPLIN ENSG00000050405 "LIM domain and actin binding 1" Q9UHB6 12 50175788-50283546 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 83.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 73.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023871, HPA052645" Enhanced Enhanced "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" 160000 "Plasma membrane, Actin filaments" "Focal adhesion sites, Cytosol" "HPA023871: AB_1852875, HPA052645: AB_2681898" "unprognostic (6.22e-2)" "unprognostic (9.39e-3)" "unprognostic (8.13e-2)" "unprognostic (1.42e-1)" "unprognostic (8.08e-2)" "prognostic unfavourable (1.76e-6)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (1.28e-3)" "unprognostic (6.27e-2)" "prognostic favourable (2.79e-4)" "unprognostic (7.12e-2)" "unprognostic (9.26e-3)" "unprognostic (1.46e-1)" "unprognostic (1.43e-1)" 50.3 19.8 6.6 22.3 6.8 0.9 34.1 73.6 6.6 30.9 49.2 10.4 21.3 35.2 31.1 22.1 25.0 18.0 31.1 12.6 6.6 5.1 29.3 11.1 23.3 11.8 7.2 4.1 21.1 12.4 12.4 18.6 42.0 15.4 28.2 42.8 20.7 27.0 22.1 10.5 16.3 90.5 33.8 10.4 23.6 30.3 11.8 6.0 12.1 17.0 20.7 18.0 41.8 21.4 0.6 4.4 1.3 2.1 5.8 13.6 2.7 24.0 0.7 7.7 11.3 35.4 35.6 29.1 60.5 42.6 48.7 39.0 9.1 35.4 1.0 5.6 83.2 27.4 6.9 55.8 42.7 15.3 7.3 10.0 2.7 3.2 22.7 3.6 14.3 23.8 16.5 17.1 49.3 17.1 7.0 4.9 15.6 4.1 4.4 1.1 3.9 3.3 4.4 18.8 0.3 11.3 28.7 5.7 12.4 8.2 16.7 25.9 7.9 2.2 26.6 20.9 16.1 19.3 9.8 2.7 0.3 4.4 22.7 4.0 8.9 0.1 0.2 1.3 6.4 1.0 2.5 0.1 8.1 7.8 4.4 0.6 3.3 5.9 0.1 5.8 2.1 1.1 13.6 2.7 6.6 6.8 73.6 5.6 6.6 5.1 7.2 4.1 15.4 6.0 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386817-66492312 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" 62000 "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavourable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 28.6 16.9 33.9 19.1 54.1 29.0 23.6 32.5 48.4 12.5 12.1 8.4 10.2 10.0 11.8 16.5 22.0 10.6 14.4 19.1 49.2 26.4 15.3 53.1 16.4 23.3 17.6 31.2 13.5 11.7 23.4 12.0 15.4 17.2 14.4 12.9 9.1 13.2 12.4 39.5 12.3 10.9 16.9 17.4 14.5 10.8 7.8 12.6 12.6 12.3 9.7 27.9 13.6 18.7 4.6 16.2 5.5 8.2 8.4 7.9 2.7 33.1 15.6 31.5 13.1 19.0 14.3 18.2 24.1 20.6 26.2 23.4 23.5 27.3 30.5 29.9 19.8 29.6 29.4 35.2 30.8 24.5 17.5 9.8 16.4 12.7 15.4 12.9 14.6 11.0 21.8 18.9 28.1 20.4 17.3 39.0 38.1 12.8 10.3 16.8 16.1 13.7 11.7 19.5 27.1 25.4 14.3 19.4 10.8 19.5 15.3 20.2 13.8 11.0 28.1 34.1 20.9 24.0 35.7 24.2 43.0 19.4 36.0 22.8 15.9 3.2 8.2 5.5 7.4 8.2 6.7 3.0 6.6 6.9 8.3 4.6 7.9 4.9 3.9 8.4 7.3 16.2 4.9 2.7 33.9 54.1 32.5 46.9 49.2 26.4 17.6 31.2 17.2 12.6 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 131.5;skeletal muscle: 197.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Enhanced "Plasma membrane,Microtubules,Cytosol" 120000 "Plasma membrane, Microtubules, Cytosol" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 39.3 14.8 60.5 18.2 50.9 6.3 16.4 29.3 56.0 26.9 26.4 80.8 15.8 13.6 25.8 27.4 27.0 24.6 20.1 110.2 63.7 57.5 20.8 13.8 22.7 12.4 86.8 26.1 26.8 18.9 14.6 9.3 24.0 59.5 21.8 18.8 25.2 14.0 34.9 197.9 25.1 15.2 35.0 131.5 18.3 16.2 21.2 41.8 7.3 15.4 31.3 14.2 24.3 18.1 9.9 8.9 6.3 19.7 10.7 13.4 6.7 21.9 17.6 22.1 16.7 32.6 58.2 9.3 41.2 45.0 34.9 39.2 14.8 13.8 18.6 9.6 62.1 14.7 28.2 37.3 39.2 26.8 11.9 12.6 19.7 19.1 44.3 8.7 10.2 48.6 46.7 42.3 51.9 45.7 16.2 21.6 27.4 12.4 12.3 10.6 13.3 36.5 6.6 20.8 23.1 22.3 18.4 8.8 13.7 31.6 12.8 21.8 9.4 8.1 61.7 33.0 25.5 34.4 26.3 15.2 11.8 8.8 42.4 10.7 31.2 6.3 5.3 2.8 13.4 9.0 6.5 9.9 9.0 10.9 5.7 9.4 4.3 6.7 2.2 10.7 19.7 8.9 10.2 6.7 60.5 50.9 29.3 51.8 63.7 57.5 86.8 26.1 59.5 41.8 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 38.6" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332" Enhanced "Plasma membrane" "Plasma membrane" "HPA058921: , HPA070332: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favourable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 3.0 12.8 33.3 2.1 29.6 1.4 2.7 24.9 73.5 3.1 1.9 4.6 0.1 1.6 4.9 3.1 2.1 6.6 3.0 2.9 38.1 22.3 5.1 2.7 2.6 1.0 28.0 18.9 4.4 26.4 14.7 24.8 1.6 23.5 4.9 1.5 4.5 4.8 5.0 1.7 1.7 2.0 4.4 44.4 1.7 3.8 10.8 4.8 0.0 3.9 0.5 0.9 2.0 0.4 0.4 0.4 2.1 0.9 2.6 0.2 0.0 0.0 3.5 4.7 13.1 1.8 0.9 0.1 2.5 2.2 5.0 3.6 3.0 0.5 0.2 1.2 2.9 2.8 5.0 2.3 2.2 1.9 6.5 0.0 4.4 2.0 1.6 0.2 2.2 1.2 0.5 3.2 0.6 1.1 5.4 0.8 1.4 1.8 0.1 0.3 12.5 5.2 0.3 7.7 0.1 2.3 0.0 38.6 14.4 4.1 3.4 4.7 5.5 0.2 1.0 6.4 9.8 9.5 4.5 0.5 0.6 0.2 4.0 0.1 1.9 2.1 0.9 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.4 0.1 0.2 1.8 2.6 0.0 0.4 0.1 0.0 33.3 29.6 24.9 41.7 38.1 22.3 28.0 18.9 23.5 4.8 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751126-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "gallbladder: 24.6;intestine: 63.8" "Cell line enhanced" "Detected in some" "A549: 37.1;HaCaT: 27.5;hTCEpi: 25.8;MCF7: 18.9;SK-BR-3: 41.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 0.5 0.1 0.3 7.9 0.3 0.0 0.7 0.2 0.2 1.5 42.8 0.2 0.2 45.9 0.7 0.8 0.4 2.4 24.6 0.2 0.5 0.2 6.9 0.4 6.8 0.2 0.3 0.3 2.2 2.0 0.0 4.2 2.1 0.2 2.2 13.0 0.2 0.5 0.5 0.2 0.3 63.8 0.7 0.2 0.2 5.8 0.2 0.2 0.3 0.2 0.8 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 37.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.7 13.6 3.2 3.6 0.0 27.5 0.0 11.5 0.0 0.0 0.0 0.0 14.6 3.9 0.0 0.0 0.5 0.0 25.8 0.1 1.4 0.0 0.0 0.1 0.0 18.9 0.0 0.2 0.0 7.6 0.0 0.1 0.3 9.3 10.3 0.4 0.1 13.1 41.8 0.0 9.1 0.0 0.0 0.0 4.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 MSN ENSG00000147065 Moesin P26038 X 65588377-65741931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338" Enhanced Enhanced "Plasma membrane" 340000000 "Plasma membrane" "CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054" "unprognostic (1.03e-1)" "unprognostic (7.89e-2)" "unprognostic (7.64e-2)" "unprognostic (5.38e-2)" "unprognostic (4.08e-3)" "unprognostic (3.51e-2)" "unprognostic (1.11e-2)" "unprognostic (1.44e-2)" "unprognostic (3.35e-2)" "unprognostic (1.70e-2)" "unprognostic (9.04e-3)" "unprognostic (1.32e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (5.68e-3)" "unprognostic (7.75e-2)" "unprognostic (7.21e-2)" "unprognostic (6.81e-2)" 36.3 17.6 10.2 40.7 14.4 38.5 98.2 8.6 18.6 25.1 21.3 19.2 7.6 6.5 33.4 14.2 15.7 21.8 20.2 53.8 11.5 10.4 25.6 29.5 102.8 85.0 17.5 5.4 28.8 19.4 5.7 10.2 24.2 30.0 23.1 13.0 16.6 16.3 21.9 13.6 19.5 18.3 41.4 21.8 31.6 17.3 9.0 12.9 18.7 26.2 17.6 38.1 22.7 28.9 16.0 36.4 54.1 69.0 28.0 37.1 81.8 27.8 21.4 21.0 17.3 25.2 33.3 0.1 70.7 45.8 39.2 30.4 0.0 4.9 23.4 63.2 62.5 19.2 22.1 50.4 51.2 43.3 6.1 64.9 37.1 0.0 23.8 78.8 105.1 24.9 10.9 72.1 63.8 86.5 31.4 73.0 62.0 0.0 46.5 59.1 26.0 40.7 24.4 37.7 17.8 41.9 0.0 0.1 0.0 56.8 0.4 22.5 0.2 42.9 137.0 44.7 28.4 60.1 46.8 26.5 40.1 25.4 32.7 100.1 49.7 30.8 44.4 30.0 37.1 58.9 27.9 16.0 20.4 29.1 36.4 13.9 14.0 21.3 54.1 28.0 69.0 5.2 15.5 81.8 10.2 14.4 8.6 18.6 11.5 10.4 17.5 5.4 30.0 12.9 MYO1B myr1 ENSG00000128641 "Myosin IB" O43795 2 191245185-191425389 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 92.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 2.7;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013607, HPA060144" Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA013607: AB_1854251, HPA060144: " "unprognostic (4.11e-3)" "unprognostic (7.36e-3)" "unprognostic (1.21e-1)" "unprognostic (4.83e-3)" "unprognostic (2.78e-1)" "unprognostic (1.59e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-2)" "unprognostic (3.25e-3)" "unprognostic (5.85e-2)" "unprognostic (4.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (2.36e-5)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" 18.8 2.5 3.3 5.9 4.3 0.2 21.8 1.4 4.7 8.2 8.0 2.1 21.6 4.2 11.8 8.2 9.0 4.9 8.9 11.6 3.6 3.1 12.2 92.7 34.5 6.6 3.6 2.3 7.8 34.3 15.0 3.1 15.7 4.4 8.5 7.4 5.8 7.5 18.6 9.3 7.5 5.4 6.7 2.7 6.6 5.0 3.6 2.0 3.6 9.3 10.4 4.8 10.3 9.9 2.7 0.4 0.0 0.0 0.0 1.2 0.0 19.9 10.3 16.8 5.0 4.6 20.0 15.2 38.1 18.9 26.4 26.3 12.6 1.8 0.0 6.3 43.7 44.3 5.5 32.8 33.3 0.0 4.8 0.0 4.8 16.1 10.9 0.4 0.1 8.0 22.7 27.5 74.3 4.8 0.0 0.0 24.3 8.4 7.6 2.4 10.9 16.4 9.8 10.7 1.5 10.3 8.5 8.5 22.4 12.9 2.2 11.5 2.0 0.6 5.8 25.3 12.7 15.2 4.4 0.1 0.0 0.2 15.3 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.3 1.4 4.7 3.6 3.1 3.6 2.3 4.4 2.0 MYO1C myr2 ENSG00000197879 "Myosin IC" O00159 17 1464186-1492812 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001768, HPA005924, CAB037023" Enhanced Enhanced "Nuclear bodies,Plasma membrane" 30000 "Nuclear bodies, Plasma membrane" "CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: " "unprognostic (3.60e-1)" "unprognostic (4.71e-3)" "unprognostic (2.89e-1)" "unprognostic (2.96e-3)" "unprognostic (1.38e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-2)" "unprognostic (1.99e-2)" "unprognostic (5.02e-2)" "unprognostic (4.66e-2)" "unprognostic (4.93e-2)" "unprognostic (3.47e-2)" 61.5 8.6 3.3 20.1 4.1 0.9 45.7 4.4 4.3 33.8 35.5 5.3 17.2 14.0 36.0 20.5 34.3 20.3 38.2 29.3 3.3 2.5 24.8 24.8 30.3 13.4 3.3 3.8 23.7 44.8 8.6 7.6 32.2 6.1 27.4 12.7 20.0 44.5 19.0 20.0 17.1 29.9 40.8 3.6 12.3 24.2 12.6 2.9 9.4 23.0 21.3 18.6 32.0 32.4 7.9 1.7 0.8 3.1 0.0 3.5 2.2 35.5 39.1 4.2 17.3 19.9 19.8 16.3 36.3 30.2 24.0 20.2 26.0 19.6 3.5 26.3 55.9 30.2 6.3 25.2 12.5 15.8 16.0 3.4 21.3 9.5 29.6 0.3 18.0 15.4 12.6 22.0 12.7 30.8 2.7 3.0 20.3 27.1 0.4 0.2 2.7 7.2 1.4 5.8 6.4 22.0 18.6 1.7 9.5 22.8 33.4 14.6 27.3 1.8 40.4 34.8 26.8 17.0 31.3 2.3 1.8 1.5 27.7 0.8 30.1 0.2 1.3 0.0 1.5 3.1 0.8 7.9 3.5 1.6 1.7 6.7 1.3 0.7 0.8 0.0 2.6 1.6 3.0 2.2 3.3 4.1 4.4 4.3 3.3 2.5 3.3 3.8 6.1 2.9 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell line enhanced" "Detected in some" "EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054050: , HPA057065: " "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favourable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.3 0.1 6.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.0 0.0 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.7 0.2 0.2 10.0 0.0 1.2 3.9 0.0 12.8 5.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.1 0.0 7.5 10.4 0.8 4.7 20.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Cell line enhanced" "Detected in some" "HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: " "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favourable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.7 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 0.9 6.0 6.3 0.1 0.0 0.0 0.0 0.1 3.8 19.1 0.0 0.0 0.7 0.0 3.1 4.1 0.0 0.0 6.1 0.0 0.0 0.3 6.7 0.0 0.0 1.6 0.5 0.1 0.0 43.1 3.1 0.0 0.0 35.1 17.2 0.0 0.1 0.0 0.0 0.2 0.0 24.0 11.2 0.1 10.0 0.0 0.1 0.0 2.7 9.0 25.4 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136949823 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: " "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 44.5 15.7 11.5 24.5 13.4 19.3 38.9 22.6 11.6 23.7 18.3 8.4 16.5 10.2 20.8 19.2 35.9 14.6 13.9 16.8 11.8 11.1 14.0 20.9 22.4 33.0 13.9 12.1 19.6 14.3 17.9 17.7 22.7 13.5 26.3 19.5 10.8 24.0 15.8 29.0 27.3 14.3 24.0 13.5 18.7 12.8 14.7 12.7 41.1 23.8 23.5 29.0 27.3 43.3 8.5 13.3 26.8 27.1 11.2 20.2 11.9 19.6 8.7 11.5 9.5 26.8 26.1 12.9 14.5 26.2 16.9 17.7 12.7 19.6 19.3 30.2 17.0 15.2 16.2 14.8 22.6 13.9 6.6 16.7 12.4 9.9 43.7 12.1 11.6 23.6 19.5 16.4 32.8 25.9 10.0 17.3 17.7 10.7 27.3 9.7 11.0 11.1 14.9 10.8 18.5 15.8 13.5 8.2 8.0 26.2 11.8 23.4 16.9 13.3 12.8 11.0 7.2 15.6 8.3 17.3 13.6 23.9 11.7 10.9 11.7 26.8 12.4 13.2 19.7 27.1 20.2 8.1 15.6 19.8 13.3 8.5 12.6 15.0 7.2 11.2 13.4 5.2 15.0 11.9 11.5 13.4 22.6 11.6 11.8 11.1 13.9 12.1 13.5 12.7 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 39.6;parathyroid gland: 123.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" 42000 "Plasma membrane" "CAB019267: , HPA050005: " "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavourable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 11.7 11.9 14.4 4.9 18.5 4.4 7.8 17.9 39.6 7.0 7.9 10.3 3.5 7.3 7.8 8.6 7.8 9.6 9.3 17.8 12.9 16.0 8.7 6.8 7.4 5.9 11.1 17.8 17.7 8.5 123.9 10.0 8.0 16.9 8.1 7.4 9.6 8.9 11.7 6.4 9.8 7.3 8.7 9.2 5.7 6.2 8.4 10.9 2.9 7.7 1.9 5.4 7.7 6.5 4.9 8.5 1.0 5.3 4.8 6.4 4.7 11.6 10.2 10.5 10.7 14.3 8.7 14.6 11.7 13.1 13.0 16.6 15.1 7.1 8.6 6.4 6.9 7.9 13.3 15.5 7.5 9.6 16.3 15.4 38.1 11.9 12.5 10.4 17.4 8.3 13.5 18.0 11.3 7.3 5.2 11.5 10.4 8.6 9.4 8.8 12.1 18.2 4.8 4.8 14.4 7.1 12.0 11.0 8.9 12.2 11.5 9.8 10.2 12.7 4.1 11.3 12.7 13.3 15.4 10.4 7.6 9.6 12.8 13.9 17.2 1.0 4.6 0.2 3.5 5.3 2.6 4.9 4.2 4.1 5.8 2.6 6.4 4.1 0.3 4.8 2.8 8.5 4.6 4.7 14.4 18.5 17.9 39.6 12.9 16.0 11.1 17.8 16.9 10.9 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: , HPA070520: " "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.6 4.9 8.7 4.5 9.6 8.8 13.3 3.5 7.1 4.5 4.0 4.6 2.8 4.8 1.5 6.4 1.6 5.2 3.0 4.9 22.8 7.5 17.2 2.0 1.9 6.0 7.9 14.4 14.0 4.6 4.3 3.5 4.5 10.4 8.0 6.8 4.4 7.0 2.8 4.1 3.3 5.5 40.1 2.4 4.9 9.0 8.0 6.3 8.2 5.0 3.6 6.0 4.0 4.9 7.5 5.9 5.1 3.5 9.3 8.0 8.4 4.3 5.0 3.7 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172578-130237304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavourable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavourable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (8.25e-4)" "unprognostic (1.65e-1)" 5.8 12.6 76.8 7.9 56.6 4.6 2.8 18.6 66.2 7.7 20.1 6.4 5.0 3.6 12.6 4.1 24.9 13.5 8.7 4.6 74.3 25.7 8.7 1.6 2.5 1.6 20.6 28.1 4.6 3.5 1.5 2.7 1.6 17.7 14.9 6.8 4.2 5.3 41.6 0.9 10.0 4.3 34.3 6.8 1.1 5.1 2.2 7.1 0.0 20.1 0.7 2.7 16.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.7 15.8 8.2 16.4 5.1 11.6 3.9 20.0 9.3 15.4 10.3 7.5 4.0 0.0 7.3 25.2 14.0 13.3 17.5 6.9 22.9 4.0 0.0 10.5 8.0 7.9 0.6 9.7 13.4 8.9 17.4 11.0 14.5 5.6 0.1 22.2 22.2 1.4 7.7 12.5 6.7 0.0 25.9 5.3 15.0 4.9 21.7 20.4 12.3 5.9 11.8 11.0 4.9 11.4 29.9 24.3 23.9 25.6 0.0 0.0 0.0 34.9 2.2 32.2 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 76.8 56.6 18.6 59.9 74.3 25.7 20.6 28.1 17.7 7.1 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favourable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 11.8 12.4 23.6 11.1 20.1 10.0 15.4 20.8 28.1 10.8 9.7 9.0 11.8 7.8 10.5 11.3 14.2 11.3 8.0 19.7 26.6 16.4 13.5 11.1 11.9 24.1 18.0 13.5 11.0 12.9 46.8 8.6 6.9 11.4 10.2 8.7 9.5 9.3 15.4 25.7 12.1 8.5 11.9 10.7 10.4 8.8 21.6 10.1 14.9 15.6 11.5 9.9 10.6 10.2 8.5 13.6 6.6 17.3 11.6 15.0 9.8 26.3 10.6 3.7 24.3 7.3 7.3 3.6 21.4 12.1 23.5 20.3 10.5 6.5 7.0 17.8 22.0 9.3 7.7 12.4 21.1 10.2 6.1 8.3 7.9 7.5 7.8 11.9 9.9 6.7 5.7 16.6 20.3 16.5 4.0 6.5 22.8 11.0 7.2 4.7 2.8 10.1 7.5 20.0 6.7 23.8 12.3 5.8 4.0 12.3 8.3 4.8 5.3 4.8 30.6 35.0 39.9 15.2 36.1 10.2 8.1 8.4 9.3 4.7 22.3 6.6 9.5 3.6 15.0 13.5 12.8 8.2 11.3 10.1 13.6 8.5 9.8 9.2 2.3 11.6 17.3 9.3 9.4 9.8 23.6 20.1 20.8 28.1 26.6 16.4 18.0 13.5 11.4 10.1 NID2 ENSG00000087303 "Nidogen 2" Q14112 14 52004803-52069228 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 52.1;BJ: 27.2;BJ hTERT+: 23.2;HHSteC: 28.9;HSkMC: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052460, HPA058772" Enhanced Enhanced "Plasma membrane" "Secreted to extracellular matrix" 2500000 "Plasma membrane" "HPA052460: AB_2681840, HPA058772: AB_2683815" "unprognostic (6.51e-2)" "unprognostic (3.55e-3)" "unprognostic (3.73e-2)" "unprognostic (3.25e-2)" "unprognostic (2.04e-1)" "unprognostic (1.94e-1)" "unprognostic (5.37e-2)" "unprognostic (3.05e-3)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (4.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.48e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (4.58e-2)" "unprognostic (2.87e-2)" "prognostic unfavourable (2.78e-4)" 15.0 5.1 0.9 5.3 1.8 0.1 7.6 0.9 1.7 12.9 8.5 5.1 9.0 1.0 9.5 7.6 9.8 6.0 10.2 17.5 1.2 0.9 6.4 2.9 5.1 3.0 1.3 1.2 16.8 13.9 10.2 2.4 32.5 2.5 13.4 3.6 17.4 4.3 8.9 3.9 1.8 3.0 11.4 1.5 1.1 6.6 4.4 0.8 0.7 18.8 3.6 2.2 10.7 5.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 13.6 0.0 52.1 20.7 0.0 27.2 23.2 2.6 2.7 0.0 0.0 0.0 4.0 3.0 1.8 1.7 0.0 0.7 0.0 0.3 0.0 0.4 0.0 28.9 0.0 0.0 107.9 0.0 10.6 0.0 1.4 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.9 4.0 0.0 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 9.9 0.1 5.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 1.8 0.9 1.7 1.2 0.9 1.3 1.2 2.5 0.8 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600614-42648741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: " "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favourable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavourable (6.01e-4)" "prognostic unfavourable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favourable (1.05e-5)" 12.9 14.4 9.8 18.8 22.2 16.3 15.9 42.0 12.3 18.8 10.4 18.5 15.4 11.8 27.2 17.4 11.0 12.0 13.1 11.2 10.9 10.5 9.5 9.7 14.6 15.5 14.5 11.3 22.7 18.4 19.2 26.9 11.1 14.1 12.9 11.1 20.4 13.2 19.5 12.0 20.0 13.3 19.4 15.0 18.5 10.1 17.8 13.8 20.6 14.9 10.9 19.4 12.9 13.9 9.3 8.5 11.7 10.0 11.1 10.2 3.6 8.9 5.1 17.1 7.0 10.2 12.5 9.6 14.5 3.7 6.0 8.2 9.0 7.2 14.1 7.0 4.4 7.9 10.1 3.6 12.4 7.1 8.4 18.1 16.2 14.5 4.4 13.9 11.9 5.1 7.2 11.9 4.5 10.6 18.2 10.9 11.4 3.7 9.5 13.6 14.7 7.5 10.1 7.7 5.8 8.4 6.8 6.0 3.6 15.6 6.5 2.4 9.5 10.1 17.0 10.9 7.9 11.8 14.0 9.5 13.2 9.8 5.8 17.1 6.6 9.2 6.2 11.7 10.2 7.7 9.4 8.9 9.8 8.5 4.7 9.3 10.0 8.7 9.1 11.1 10.0 8.5 8.3 3.6 9.8 22.2 42.0 12.3 10.9 10.5 14.5 11.3 14.1 13.8 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.2 24.6 15.8 15.0 14.3 13.3 11.7 9.9 17.9 24.3 18.0 20.8 17.2 11.8 8.1 18.0 20.1 9.7 26.0 18.7 4.4 10.5 11.9 4.4 23.8 15.1 11.5 7.2 11.3 9.5 25.3 8.5 17.2 15.4 10.6 16.9 10.2 12.0 22.0 16.9 27.2 5.7 19.7 11.5 28.2 14.9 9.1 11.2 12.0 23.9 10.8 14.6 8.0 16.0 18.9 13.9 10.9 16.2 8.5 15.2 9.8 14.0 16.1 13.3 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.1;HMC-1: 25.6;SK-MEL-30: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: " "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 5.5 3.8 5.3 20.2 6.1 12.2 4.1 22.3 7.6 2.7 12.3 5.4 2.3 8.6 3.5 2.8 2.9 3.2 12.1 5.5 6.4 4.3 3.2 6.4 20.3 21.2 7.5 4.2 2.6 16.6 0.8 4.2 17.7 7.7 3.9 10.1 10.6 5.0 4.4 3.8 6.2 14.9 3.5 9.9 12.1 5.1 1.4 7.4 15.2 3.4 0.4 15.3 6.2 4.4 2.2 4.1 10.9 13.3 1.6 6.8 2.4 0.0 0.0 2.7 0.1 5.1 4.9 0.1 1.1 8.6 0.5 1.1 0.1 0.0 19.1 0.1 0.3 0.8 0.0 1.0 0.5 0.5 2.5 11.2 0.2 0.0 5.2 1.8 25.6 2.3 0.6 5.0 4.7 0.0 0.1 0.1 8.2 0.1 6.7 0.1 0.2 0.7 5.1 1.3 0.0 0.9 4.1 0.5 1.0 0.0 0.2 19.9 0.6 1.9 0.1 0.6 0.3 0.0 0.6 3.2 0.8 6.8 5.5 6.4 4.7 10.9 1.4 1.9 2.6 6.3 6.5 2.2 6.6 4.6 1.8 1.4 5.4 4.0 2.3 1.6 13.3 4.1 6.8 2.4 5.3 6.1 22.3 7.6 6.4 4.3 7.5 4.2 7.7 7.4 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell line enhanced" "Detected in many" "AN3-CA: 16.2;EFO-21: 15.0;REH: 26.6;SH-SY5Y: 17.1;U-2197: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favourable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.3 8.4 16.2 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.0 0.1 1.5 4.2 0.0 0.2 0.0 8.3 0.0 3.4 5.3 5.9 0.0 0.1 3.8 0.0 0.7 0.0 0.6 2.9 0.0 1.1 8.5 0.6 5.0 3.4 2.4 26.6 0.0 0.1 0.4 0.0 0.9 17.1 4.3 0.0 0.1 1.5 4.0 0.0 0.0 8.8 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128928-94181972 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavourable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 13.5 9.4 7.9 13.5 14.3 3.8 18.0 7.8 14.8 10.1 11.8 5.6 4.3 6.1 10.8 6.6 9.4 8.7 13.7 13.4 5.6 10.2 8.7 19.4 14.7 6.7 7.4 9.2 9.0 8.5 10.1 7.8 11.0 8.7 9.4 8.6 3.9 9.7 8.6 29.8 11.5 7.4 14.7 5.0 9.6 10.7 12.3 7.4 12.7 10.2 13.9 8.7 13.6 14.1 2.6 5.0 3.6 7.4 4.2 5.1 6.1 11.6 5.0 13.2 7.9 12.3 16.8 8.6 14.6 31.2 12.6 15.6 12.7 18.5 3.7 13.7 14.9 24.9 10.3 24.2 12.8 16.0 5.4 17.4 5.2 6.5 11.9 8.9 15.6 13.2 17.1 16.4 14.8 10.5 11.2 13.7 14.0 3.7 14.7 2.1 10.4 9.0 17.6 17.5 4.6 8.2 11.7 5.5 16.0 10.2 5.9 7.0 12.5 4.6 7.5 25.1 13.0 8.2 14.5 2.2 8.5 6.2 10.4 9.2 15.9 3.6 7.4 0.5 4.3 4.2 5.0 2.6 3.5 4.4 5.0 2.4 3.2 3.6 0.5 4.2 2.6 0.8 5.1 6.1 7.9 14.3 7.8 14.8 5.6 10.2 7.4 9.2 8.7 7.4 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 16.4;RH-30: 46.0;RT4: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: " "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavourable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavourable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.5 7.6 11.5 11.2 0.0 1.4 0.0 0.7 0.3 0.7 9.9 0.0 0.0 0.0 5.7 0.4 14.4 1.3 0.0 16.4 0.0 10.4 0.0 11.9 0.2 0.0 6.7 3.4 0.3 4.1 2.8 0.0 0.0 3.4 0.0 0.0 0.0 3.3 1.5 0.0 46.0 0.0 0.3 24.2 0.3 0.1 0.1 0.4 0.5 0.7 2.5 0.0 9.3 2.4 2.5 0.0 0.0 0.0 0.0 7.2 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408829 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" 40000 Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: , HPA060836: " "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 26.7 25.7 25.5 25.0 23.9 23.0 22.4 23.4 28.5 22.8 25.9 18.3 21.6 21.1 25.8 21.6 32.2 20.5 23.4 30.2 23.4 20.4 25.2 31.8 20.5 20.2 23.2 23.5 23.4 28.2 23.3 18.0 28.8 24.2 23.0 22.0 19.0 27.8 26.4 103.5 24.8 19.6 26.9 22.2 20.5 22.6 19.7 24.3 20.1 22.4 37.2 25.2 24.1 28.2 11.3 15.8 24.2 11.9 20.4 14.2 4.6 30.7 26.9 18.2 23.2 14.1 14.7 11.8 25.6 14.8 20.7 17.5 27.2 15.4 13.6 22.7 24.1 16.7 21.9 25.6 20.2 19.3 24.3 13.7 26.0 23.6 20.7 25.7 13.6 15.4 19.3 22.7 37.3 20.6 32.3 24.8 20.2 64.2 35.7 35.1 23.3 29.2 16.5 18.2 23.5 20.9 23.7 18.7 37.4 19.1 30.5 13.0 13.4 13.5 18.6 27.9 30.9 33.0 39.9 23.9 27.3 30.1 22.4 23.1 29.1 7.6 9.4 8.6 12.4 11.9 11.1 11.3 11.5 8.9 7.4 11.1 8.3 10.3 24.2 20.4 10.6 15.8 14.2 4.6 25.5 23.9 23.4 28.5 23.4 20.4 23.2 23.5 24.2 24.3 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavourable (1.48e-4)" "prognostic favourable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.5 5.5 14.5 34.9 8.3 11.0 27.1 12.3 22.2 17.6 29.2 28.7 2.4 0.0 5.3 32.9 18.3 26.9 25.6 12.4 0.1 24.5 4.3 19.5 19.8 17.3 27.4 0.1 15.8 42.8 16.8 20.0 12.6 7.8 32.5 7.7 53.3 18.3 8.4 36.3 42.3 16.1 25.2 2.3 1.1 16.2 15.7 14.3 9.0 6.0 98.9 12.2 46.8 0.1 2.9 15.3 17.9 13.7 26.8 6.7 27.4 35.6 38.3 22.6 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favourable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.8 10.1 10.1 12.8 12.6 17.1 13.5 16.8 13.2 11.0 13.2 13.1 17.2 18.7 24.6 12.7 23.3 13.5 14.2 17.5 15.5 9.1 11.4 15.6 10.2 9.0 23.3 13.3 10.0 9.5 11.1 13.0 13.9 13.4 28.0 12.1 15.3 11.6 7.1 17.1 9.4 12.5 18.8 18.1 13.6 26.0 11.5 11.8 22.4 15.9 7.1 25.2 14.9 15.7 22.4 16.4 8.8 12.5 29.7 27.6 9.3 12.3 13.3 21.8 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell line enriched" "Detected in some" 9 "ASC diff: 75.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Supported "Vesicles,Lipid droplets,Plasma membrane,Cytosol" 11000 "Lipid droplets, Plasma membrane" "Vesicles, Cytosol" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (8.31e-4)" "prognostic unfavourable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 75.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.4 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 7700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB022558: , CAB069426: , HPA065425: " "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 36.4 23.0 80.2 24.8 27.5 25.6 46.7 19.6 22.4 19.1 18.9 20.4 21.6 29.2 24.7 20.3 22.6 22.8 26.2 22.8 46.3 11.8 22.0 28.2 22.0 59.9 24.9 10.4 19.6 37.3 20.6 43.2 23.1 20.0 29.0 25.0 18.3 26.4 21.6 26.3 18.2 26.0 71.1 22.2 62.2 44.1 22.0 27.2 30.5 33.9 26.6 16.4 14.0 27.6 25.6 28.2 18.3 23.6 20.7 32.5 59.8 27.2 26.9 18.9 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: , HPA038468: " "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavourable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.9 29.6 30.6 21.4 16.4 16.7 23.8 21.9 21.3 25.5 23.5 51.2 25.4 28.8 21.6 20.4 23.6 33.7 24.8 33.8 27.8 14.1 33.3 30.0 17.3 15.7 31.5 29.7 16.5 16.7 26.2 28.4 23.2 28.0 21.5 18.2 33.4 31.6 24.3 15.3 17.6 29.7 41.8 28.0 17.0 36.3 17.4 20.7 31.1 24.7 45.2 36.6 16.9 23.0 25.2 23.9 26.7 18.6 17.0 23.7 37.8 18.2 14.0 26.7 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 PRKCA PKCA ENSG00000154229 "Protein kinase C alpha" P17252 17 66302636-66810743 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003844, HPA006563, HPA006564, CAB016290" Enhanced Approved Enhanced "Plasma membrane,Cytosol" 1900000 Cytosol "Plasma membrane" "CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625" "unprognostic (3.06e-1)" "unprognostic (3.56e-2)" "unprognostic (1.38e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (7.41e-3)" "unprognostic (7.43e-2)" "unprognostic (6.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.35e-3)" "unprognostic (8.77e-2)" 4.0 19.6 26.5 9.0 22.8 2.5 3.0 10.8 33.9 7.0 13.8 19.0 3.5 14.6 14.8 6.7 4.7 6.1 10.8 5.8 31.6 15.6 16.7 6.5 6.0 8.4 18.7 15.6 20.4 5.5 1.7 6.0 6.5 17.6 17.2 11.2 7.0 3.1 22.3 6.6 3.8 12.7 13.7 15.0 7.9 7.9 3.7 14.4 0.4 4.5 1.3 5.9 9.5 9.5 0.0 1.4 0.1 2.7 0.1 4.0 1.0 2.3 12.3 2.5 2.6 6.2 15.9 0.3 13.3 8.7 9.6 8.2 1.4 1.5 3.1 3.6 21.4 0.3 1.3 1.5 20.9 5.1 3.0 0.0 7.3 6.4 8.5 3.8 20.9 6.9 0.6 12.0 10.3 8.2 8.0 0.0 14.8 0.7 7.7 2.3 1.0 6.6 1.4 18.8 0.0 3.4 2.0 1.5 8.5 4.4 2.5 0.1 0.3 5.4 24.5 16.7 9.7 10.4 8.3 0.0 0.0 0.3 53.0 0.0 8.2 0.1 0.6 0.0 0.5 0.8 1.5 0.0 2.5 1.2 1.1 0.0 4.0 2.3 0.0 0.1 2.7 1.4 0.5 1.0 26.5 22.8 10.8 28.2 31.6 15.6 18.7 15.6 17.6 14.4 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222314 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 62.4;urinary bladder: 48.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.0;U-2197: 56.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 6.0 3.0 6.7 5.7 5.1 0.2 4.0 7.3 4.8 23.1 32.9 5.1 9.6 3.0 34.1 8.0 9.7 8.1 12.4 7.0 7.4 4.5 3.3 1.8 4.9 1.7 6.4 5.4 8.2 1.6 2.9 3.5 12.3 6.7 24.9 7.5 3.6 2.8 26.9 4.7 3.1 7.0 62.4 6.6 1.1 8.7 4.3 7.2 1.4 15.1 3.9 1.7 48.9 11.2 0.3 1.5 1.3 0.6 0.9 2.0 0.3 4.7 1.9 6.8 4.8 10.5 32.0 6.3 14.0 24.3 12.3 12.8 4.1 2.3 0.9 4.4 22.4 1.7 7.1 5.1 14.7 3.5 3.3 3.4 3.1 3.2 6.5 1.8 0.5 11.9 5.9 15.3 14.4 6.4 5.2 2.9 13.6 4.0 1.5 1.9 2.5 2.6 1.7 10.1 1.4 8.5 3.3 3.5 2.4 7.0 3.3 3.6 3.0 2.0 8.5 19.2 6.0 56.4 8.1 2.5 2.8 2.3 10.8 3.8 9.4 0.3 0.4 1.3 0.3 0.4 0.0 0.3 1.1 0.5 0.3 0.3 2.0 0.8 0.0 0.9 0.6 1.5 0.0 0.3 6.7 5.1 7.3 4.8 7.4 4.5 6.4 5.4 6.7 7.2 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 5.2 9.9 6.1 12.5 8.1 6.1 17.3 14.3 7.0 5.3 9.2 3.3 5.8 8.0 6.4 5.9 9.2 6.2 8.7 6.2 5.5 6.7 8.5 11.3 6.6 5.7 8.4 1.5 8.2 12.1 9.3 3.2 9.4 6.0 5.6 7.4 3.1 8.2 6.2 5.2 11.8 9.7 8.6 5.6 10.1 6.5 18.9 7.2 21.9 11.0 8.3 14.5 6.4 5.7 3.1 2.3 0.1 2.0 1.7 2.9 0.8 4.8 7.2 1.7 3.6 4.2 5.1 12.8 5.6 1.0 1.6 1.7 3.4 9.3 17.1 9.1 3.4 10.5 5.5 1.5 2.8 14.3 11.3 12.3 12.2 4.9 3.5 5.9 4.9 3.7 5.0 1.7 2.3 2.7 9.3 11.3 4.9 1.6 7.0 6.1 6.5 3.0 8.4 8.6 18.2 7.6 2.2 5.6 6.4 9.7 6.3 6.6 7.2 11.4 4.2 1.0 7.2 4.1 0.2 20.3 8.3 10.2 1.9 13.0 4.8 0.1 0.7 0.1 0.8 2.0 2.1 3.1 1.7 2.7 1.6 2.1 2.9 1.0 0.1 1.7 1.1 2.3 2.1 0.8 6.1 8.1 14.3 7.0 5.5 6.7 8.4 1.5 6.0 7.2 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597240-79767815 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" 6500000 "Plasma membrane" "CAB013524: , HPA052968: , HPA074461: " "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavourable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.5 10.1 15.5 10.7 30.2 0.4 7.3 12.5 22.0 15.9 9.4 14.7 1.6 3.5 10.5 8.2 13.7 5.6 8.6 9.0 12.3 12.4 3.7 4.0 8.3 9.3 14.7 8.9 18.4 2.3 2.1 29.6 8.4 12.2 14.5 6.9 8.5 5.5 13.8 4.5 21.8 5.4 11.4 8.1 9.2 5.0 10.8 15.7 14.0 5.5 8.8 18.8 13.2 14.1 1.0 0.7 0.0 0.4 0.1 3.1 0.1 0.0 10.9 10.4 16.6 14.5 9.6 0.5 8.3 11.2 6.6 5.6 0.2 4.6 0.0 0.0 10.3 4.3 12.6 8.6 8.3 0.1 16.0 6.3 21.6 17.0 3.5 0.1 1.6 15.9 11.8 25.0 11.9 6.6 0.8 19.7 6.8 5.1 0.0 0.0 13.2 3.9 0.3 10.9 0.1 0.0 3.5 8.1 5.5 17.9 4.1 6.6 12.7 0.1 0.1 22.1 9.7 13.1 14.0 0.7 0.0 0.0 20.1 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.7 0.3 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 15.5 30.2 12.5 13.6 12.3 12.4 14.7 8.9 12.2 15.7 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 44.7" "Cell line enhanced" "Detected in many" "A549: 33.4;HBEC3-KT: 17.8;HeLa: 21.7;U-2197: 19.5" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 10 "dendritic cells: 8.9;monocytes: 6.9" "Low region specificity" "Detected in many" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" 390000 Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: " "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavourable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 4.7 0.6 0.6 3.3 3.1 1.5 2.2 0.6 1.7 3.7 1.2 1.3 0.1 0.4 2.4 1.6 7.4 1.6 1.6 7.9 0.5 0.7 10.2 0.1 14.2 4.6 1.7 0.1 1.2 5.3 0.0 0.3 5.6 3.5 3.6 1.0 0.3 2.0 1.6 2.5 44.7 1.0 1.8 1.5 2.1 0.7 1.4 0.4 0.5 1.7 2.1 4.9 3.7 4.0 0.7 8.9 0.0 6.9 0.0 0.3 0.4 2.8 33.4 0.0 0.0 3.2 2.1 0.0 2.3 12.2 2.9 4.9 0.9 1.0 0.0 7.5 5.8 8.8 0.0 17.8 1.6 0.1 0.0 0.1 21.7 6.0 0.8 0.0 0.1 1.5 9.1 7.1 8.0 0.6 0.0 0.0 15.7 0.2 0.0 0.0 0.2 4.1 0.0 2.4 1.8 9.7 7.2 0.5 0.0 2.1 2.5 0.7 0.1 0.2 3.0 1.2 1.9 19.5 2.4 0.5 0.6 0.0 15.6 0.2 7.4 0.0 0.2 0.0 0.0 3.6 0.3 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.9 8.9 0.1 0.4 0.6 3.1 0.6 1.7 0.5 0.7 1.7 0.1 3.5 0.4 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 419.2" "Cell line enhanced" "Detected in many" "A549: 112.8;ASC diff: 146.4;BJ hTERT+: 281.6;fHDF/TERT166: 201.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Enhanced "Plasma membrane" 13000000 "Plasma membrane" "CAB002618: , CAB027387: , CAB058698: , CAB068227: , CAB068228: , HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favourable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 125.9 10.1 2.6 29.2 8.3 75.2 171.6 2.2 4.6 52.1 33.9 2.7 25.8 7.3 26.8 52.2 58.6 27.9 34.7 59.9 3.0 1.7 27.8 6.1 80.7 53.2 10.8 3.1 12.7 6.7 0.0 3.0 46.9 6.6 49.5 28.0 19.3 29.8 13.4 25.4 44.5 25.5 38.5 8.9 55.9 17.2 18.2 6.2 8.5 23.7 57.5 26.4 34.9 58.2 18.6 213.1 281.6 293.3 17.3 162.7 419.2 0.5 112.8 0.5 3.3 146.4 100.9 0.1 71.5 281.6 1.4 6.3 0.8 7.9 0.0 13.1 201.4 2.8 0.4 1.0 1.1 16.1 0.0 48.2 25.1 2.5 0.1 4.2 81.6 15.7 1.1 2.8 0.6 0.1 0.4 0.1 102.5 0.4 0.1 50.0 0.3 43.3 2.5 0.1 106.3 4.4 3.0 4.3 0.5 1.2 54.5 0.4 3.3 60.4 0.1 0.3 0.6 96.1 0.4 3.5 24.0 0.5 0.2 53.7 5.5 49.5 293.3 30.8 141.2 201.4 147.2 18.6 127.2 112.3 213.1 6.2 22.4 66.5 281.6 17.3 253.9 37.4 162.7 419.2 2.6 8.3 2.2 4.6 3.0 1.7 10.8 3.1 6.6 6.2 S100A6 "2A9, CABP, CACY, PRA" ENSG00000197956 "S100 calcium binding protein A6" P06703 1 153534599-153536244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 375.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002601, HPA007575, CAB040549, CAB047354" Enhanced Enhanced "Plasma membrane,Cytosol" 5100000 "Plasma membrane, Cytosol" "CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859" "unprognostic (8.80e-3)" "unprognostic (6.96e-2)" "unprognostic (2.31e-1)" "unprognostic (2.47e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-1)" "unprognostic (6.86e-3)" "unprognostic (1.66e-1)" "unprognostic (3.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.88e-1)" "unprognostic (1.46e-2)" "prognostic favourable (7.56e-4)" 126.4 32.6 14.8 104.9 29.9 73.8 223.6 13.3 14.6 95.4 176.8 10.1 51.2 70.2 65.0 135.5 126.5 42.2 264.5 112.3 13.0 22.5 103.4 6.0 151.9 61.5 45.6 7.9 38.1 13.5 0.5 17.7 100.1 27.3 85.1 85.5 28.5 58.7 55.2 59.1 45.1 98.1 88.9 35.5 27.5 69.9 29.6 17.8 4.9 76.9 183.0 36.2 150.9 145.0 30.7 130.1 303.7 180.7 9.1 69.2 201.7 77.6 86.9 0.0 7.2 146.3 189.8 0.2 95.2 237.8 48.3 63.4 6.0 162.4 0.1 30.2 141.3 33.7 1.5 136.7 22.8 31.9 0.0 16.2 58.1 5.3 55.4 0.7 11.2 88.5 113.7 51.7 89.5 107.1 0.0 0.1 120.3 11.7 0.2 6.6 0.1 143.0 0.0 10.8 28.1 375.0 72.1 22.4 3.9 129.5 131.9 97.9 18.1 25.2 156.4 46.7 12.2 95.3 154.5 0.2 0.2 0.2 181.3 17.4 99.6 139.8 180.7 74.1 62.0 96.8 67.3 30.7 58.5 60.3 130.1 17.2 37.3 49.5 303.7 9.1 86.9 68.3 69.2 201.7 14.8 29.9 13.3 14.6 13.0 22.5 45.6 7.9 27.3 17.8 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 37.7;SK-BR-3: 40.9" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favourable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.1 8.3 0.2 0.2 0.1 0.6 0.1 1.3 0.1 0.2 0.0 37.7 1.4 1.7 0.0 0.4 40.9 0.0 4.3 0.3 0.0 0.1 0.3 0.8 0.0 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribbled planar cell polarity protein" Q14160 8 143790920-143815379 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: , HPA064312: " "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 13.0 6.1 15.1 10.8 12.2 9.4 15.9 10.1 13.9 15.1 18.4 17.5 9.8 14.8 9.4 5.9 36.6 11.6 11.9 8.0 12.2 7.7 10.2 13.6 11.5 12.9 13.5 12.8 10.9 17.2 11.2 9.6 9.5 11.8 10.9 7.6 7.5 22.9 11.2 36.8 33.3 16.3 11.2 9.7 11.2 17.0 10.1 16.4 14.0 9.1 11.9 9.6 11.6 17.8 0.6 0.5 0.2 0.4 0.2 1.5 0.6 18.5 15.0 6.9 8.7 2.5 3.2 11.6 10.4 3.0 4.8 4.0 6.6 12.1 7.3 12.7 3.0 19.4 3.7 14.0 0.9 8.1 20.6 10.2 12.9 11.5 5.7 4.2 5.8 2.7 13.6 4.7 4.0 5.3 12.9 2.6 3.7 36.9 11.0 9.1 5.2 19.0 13.3 6.4 8.2 2.5 18.7 15.0 11.0 11.8 13.0 11.0 16.4 10.2 10.1 5.3 22.2 9.4 14.6 9.2 9.0 7.5 5.5 4.3 8.3 0.1 0.1 0.1 0.6 0.4 1.5 0.6 0.4 1.2 0.5 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.6 15.1 12.2 10.1 13.9 12.2 7.7 13.5 12.8 11.8 16.4 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: " "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavourable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavourable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 19.9 4.7 14.4 12.3 10.0 8.5 47.4 10.8 8.2 8.5 13.7 15.8 11.6 21.9 15.1 9.7 19.1 20.1 20.1 16.1 13.7 20.4 18.0 12.8 18.3 17.7 22.9 1.9 11.9 24.6 12.6 24.7 20.5 22.7 14.6 9.5 3.9 13.5 11.5 46.6 15.0 12.0 22.8 15.1 10.5 0.3 16.0 8.4 20.9 0.6 16.0 0.9 8.7 13.8 8.2 14.5 16.1 15.9 7.7 6.7 22.1 23.8 14.5 10.1 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 34.6" "Group enriched" "Detected in many" 4 "dendritic cells: 34.6;monocytes: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavourable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 39.3 5.7 3.4 16.0 5.4 16.2 45.0 0.9 3.0 20.7 15.8 5.0 50.4 4.9 14.3 33.7 33.9 18.1 31.2 10.0 4.5 2.2 23.7 4.1 23.4 17.7 8.2 0.9 33.3 24.6 0.2 9.1 25.8 4.9 35.2 13.8 5.2 99.0 55.7 6.9 18.6 12.1 23.1 5.3 19.8 17.9 21.7 6.1 14.9 6.5 28.4 25.9 48.3 44.9 7.0 34.6 0.9 22.4 6.9 5.6 7.4 24.2 44.9 10.8 16.3 28.2 24.0 25.6 34.7 39.7 26.1 37.9 40.7 27.5 26.6 17.0 86.1 39.2 31.5 41.2 19.5 17.6 28.5 44.2 17.2 38.1 73.0 30.7 26.1 39.0 103.2 30.6 77.6 13.8 46.6 70.6 13.9 41.3 14.0 82.7 18.9 19.8 16.0 12.2 37.9 14.6 53.1 16.7 12.2 17.1 46.8 37.2 26.9 40.6 10.3 15.7 25.1 12.2 28.2 43.8 42.3 22.2 29.5 38.4 38.4 0.0 11.5 0.9 5.3 19.9 4.4 7.0 3.1 3.7 17.8 2.5 0.7 2.3 0.3 6.9 22.4 34.6 5.6 7.4 3.4 5.4 0.9 3.0 4.5 2.2 8.2 0.9 4.9 6.1 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell line enhanced" "Detected in many" "BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" 36000000 "Plasma membrane" "CAB002759: , HPA031345: , HPA058494: " "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavourable (3.65e-8)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavourable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.6 15.3 12.7 3.2 1.5 0.5 44.2 7.0 15.2 8.6 12.8 71.8 29.7 4.0 21.0 2.1 9.9 2.8 16.3 3.8 2.4 2.6 6.6 8.9 49.0 4.4 3.6 1.9 1.8 12.6 5.4 5.9 1.4 14.8 0.9 3.9 18.9 1.6 2.5 8.1 3.9 1.6 4.1 5.6 7.9 5.2 6.7 4.7 8.2 26.0 3.0 1.1 4.6 3.2 7.9 5.7 1.4 15.8 0.7 1.5 2.4 15.6 2.5 6.4 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: " "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 3.0 1.0 2.6 0.0 2.0 1.1 0.2 1.8 7.6 1.0 4.2 0.0 10.4 0.4 1.6 0.1 7.9 0.0 0.8 1.5 0.0 6.5 0.0 0.9 0.1 0.3 0.0 0.0 1.5 0.7 0.8 0.2 0.6 0.6 0.9 0.2 0.9 0.1 0.1 2.3 0.7 0.0 1.3 2.8 2.3 1.0 0.3 0.8 0.1 2.4 0.0 0.1 0.0 0.1 0.2 11.3 0.2 1.0 3.9 3.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 SNX9 "SDP1, SH3PX1, SH3PXD3A" ENSG00000130340 "Sorting nexin 9" Q9Y5X1 6 157700387-157945077 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031410, HPA057203" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA031410: AB_10603339, HPA057203: " "unprognostic (1.63e-3)" "prognostic unfavourable (5.95e-4)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (8.09e-2)" "unprognostic (1.40e-2)" "unprognostic (4.06e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (7.93e-2)" "unprognostic (4.99e-3)" "unprognostic (4.45e-2)" "unprognostic (2.42e-1)" "prognostic favourable (9.95e-4)" "unprognostic (2.14e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" 44.7 18.9 13.0 16.5 14.7 17.2 35.4 6.7 16.2 27.4 24.6 19.8 43.5 18.1 32.1 19.5 31.4 17.2 26.4 20.4 12.2 10.8 17.8 25.4 14.6 22.5 19.7 11.4 19.8 22.5 17.7 10.8 45.0 13.3 25.0 17.7 11.1 25.2 41.7 16.5 21.2 28.0 44.6 16.4 19.8 21.5 10.9 18.4 5.0 18.4 17.9 20.3 34.0 40.2 4.1 11.2 1.3 7.3 0.5 6.7 1.0 7.8 5.1 5.5 6.4 27.4 24.4 11.6 15.7 44.3 10.7 14.4 4.5 8.0 0.0 7.8 24.3 5.2 6.4 10.5 9.0 6.4 7.5 4.9 7.9 6.8 13.7 2.6 10.0 14.4 9.4 11.0 10.8 14.8 24.9 0.0 5.2 4.4 0.0 3.9 4.3 6.7 0.0 5.5 8.9 17.3 4.6 3.5 6.4 10.0 4.6 24.0 2.2 5.6 12.0 11.9 5.4 38.0 8.3 0.0 0.0 0.0 23.8 2.0 6.9 0.0 1.0 1.3 0.6 3.2 2.4 4.1 1.7 1.3 2.0 3.4 6.7 2.1 0.1 0.5 7.3 11.2 2.8 1.0 13.0 14.7 6.7 16.2 12.2 10.8 19.7 11.4 13.3 18.4 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 55.6 48.7 34.2 34.2 45.8 31.9 28.4 47.0 28.1 32.0 24.2 63.1 35.4 66.7 49.5 43.3 20.2 49.0 34.6 26.4 49.2 60.9 107.6 63.9 90.2 30.3 47.5 40.3 33.1 26.4 44.8 24.9 35.9 74.2 85.3 38.5 90.4 51.0 47.9 51.4 52.0 43.9 69.0 103.7 62.5 34.2 37.4 31.4 87.1 46.1 45.2 53.0 42.0 42.0 24.9 55.1 33.6 34.6 65.2 141.0 79.0 50.8 69.3 33.0 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 158.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 11000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: " "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 12.9 12.8 22.1 13.9 23.0 10.5 17.8 20.1 21.8 18.1 18.4 35.0 13.6 17.8 23.1 15.4 22.7 16.5 14.7 19.0 23.3 21.2 19.6 16.9 13.4 15.3 33.0 14.3 16.3 15.1 20.9 17.8 20.6 26.3 20.2 20.7 14.6 18.3 15.7 30.1 14.4 25.2 19.0 54.7 13.8 15.6 13.3 22.3 18.4 20.1 15.9 19.0 16.8 16.4 17.6 16.9 27.8 17.8 16.7 20.7 12.3 5.3 6.2 4.9 4.5 4.6 5.5 5.6 3.3 4.5 6.0 5.8 10.3 5.1 4.4 5.2 2.7 4.2 5.2 11.5 6.9 7.8 5.9 6.0 4.3 8.0 6.4 4.9 7.2 4.4 8.3 7.1 10.3 3.5 6.5 6.8 158.8 6.5 7.6 4.4 7.8 3.3 5.3 12.9 6.3 6.5 6.0 9.0 6.6 4.0 4.9 6.9 4.6 2.9 3.1 5.4 6.5 3.3 5.8 6.5 6.2 3.4 6.7 5.3 6.3 22.6 16.2 27.8 14.4 17.8 15.4 17.6 16.7 14.0 16.9 16.2 17.5 13.2 24.1 16.7 15.7 16.4 20.7 12.3 22.1 23.0 20.1 21.2 23.3 21.2 33.0 14.3 26.3 22.3 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 104.0;hTCEpi: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.4 9.7 0.8 4.4 104.0 29.9 0.0 25.9 25.7 7.3 11.5 1.2 1.9 11.8 6.4 32.2 2.5 5.4 24.0 13.0 7.2 2.2 27.4 21.3 3.7 56.4 10.1 5.8 49.5 85.0 11.4 15.2 26.0 5.9 15.8 15.8 7.7 0.3 7.7 11.8 3.0 1.4 0.0 25.6 5.7 0.2 1.0 0.1 21.6 19.2 11.1 6.5 8.4 33.0 16.9 5.3 16.8 2.4 6.7 7.3 0.7 6.5 10.2 9.0 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favourable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 26.5 28.2 28.6 23.8 29.6 14.1 23.5 24.2 28.0 21.4 24.0 24.4 16.9 28.3 24.1 19.8 26.4 19.6 23.7 24.6 26.7 18.0 21.7 25.2 25.8 22.5 38.1 22.3 22.7 19.3 33.6 14.9 27.0 32.4 19.8 22.0 14.0 21.3 21.8 30.3 32.7 26.7 27.7 26.1 31.4 22.7 10.7 31.5 19.2 21.3 17.3 26.7 25.4 29.4 11.9 14.8 20.6 18.2 18.2 14.9 8.6 18.2 26.2 5.9 13.2 20.0 20.4 12.7 16.9 29.9 18.1 18.7 8.0 19.9 12.4 22.0 29.9 13.3 5.5 19.7 17.4 22.2 16.8 8.9 18.3 21.8 22.7 10.3 30.1 19.4 13.8 31.3 23.4 24.0 10.4 14.5 32.1 28.7 9.7 15.9 12.3 14.1 8.3 17.8 16.1 18.0 13.6 4.9 9.3 14.9 15.4 6.2 12.3 13.7 25.7 18.4 8.2 20.6 9.4 15.6 12.6 5.4 27.7 16.7 11.1 14.6 17.7 20.6 14.9 18.2 12.9 9.7 12.5 14.5 14.8 11.9 9.5 12.2 18.5 18.2 15.8 8.6 6.8 8.6 28.6 29.6 24.2 28.0 26.7 18.0 38.1 22.3 32.4 31.5 TBC1D10A "AC004997.C22.2, EPI64, TBC1D10" ENSG00000099992 "TBC1 domain family member 10A" Q9BXI6 22 30291990-30327046 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA007725, HPA008142, HPA076041" Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA007725: , HPA008142: AB_1080209, HPA076041: " "unprognostic (3.37e-2)" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (1.10e-2)" "unprognostic (2.11e-3)" "unprognostic (1.20e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-1)" "unprognostic (6.40e-2)" "unprognostic (1.08e-1)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-2)" "unprognostic (7.52e-2)" 13.5 10.7 8.4 14.5 13.4 7.8 14.8 10.5 13.6 16.5 12.0 4.6 17.6 9.3 9.7 16.0 31.5 11.6 13.8 6.4 8.4 6.6 16.0 10.8 14.3 15.6 6.0 6.5 16.2 12.7 8.9 13.0 35.7 8.1 13.6 6.1 17.3 15.0 19.4 4.3 27.1 10.4 10.5 7.0 15.8 10.6 17.5 6.1 19.8 14.6 10.2 22.7 12.7 23.2 13.3 22.3 21.0 23.9 12.9 26.1 17.1 11.5 4.6 1.9 6.1 5.8 7.3 15.1 6.8 10.1 8.0 12.9 5.3 4.6 5.8 6.6 11.9 11.5 2.9 6.4 4.3 4.4 7.8 1.6 4.0 3.8 14.9 2.3 8.3 9.7 10.6 15.9 2.7 3.6 3.0 5.7 6.0 14.1 16.7 5.0 1.2 6.0 7.5 8.2 5.3 8.0 11.6 3.2 2.5 6.9 10.7 15.8 9.1 1.5 6.6 15.2 6.8 8.3 3.6 5.6 2.4 5.3 10.6 3.5 8.6 17.0 8.9 21.0 16.5 17.1 18.2 8.4 19.3 16.9 12.8 13.3 26.1 21.3 6.0 12.9 23.9 22.3 16.2 17.1 8.4 13.4 10.5 10.5 8.4 6.6 6.0 6.5 8.1 6.1 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: " "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favourable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.2 1.7 4.2 4.7 20.1 19.7 23.2 8.1 5.9 12.9 7.0 6.4 19.4 7.6 8.1 4.5 32.7 6.9 17.0 14.7 27.2 5.0 7.4 4.6 32.8 5.6 3.0 14.0 15.3 12.3 10.1 6.0 27.1 4.4 5.2 6.7 7.4 1.1 0.4 10.4 11.6 3.9 6.1 0.8 33.3 35.5 1.9 3.3 2.9 20.7 0.6 6.7 1.6 38.8 9.7 10.5 7.5 8.2 5.3 1.1 0.1 11.1 4.3 3.5 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 TMEM63B "C6orf110, dJ421H19.2, DKFZp434P0531" ENSG00000137216 "Transmembrane protein 63B" Q5T3F8 6 44126914-44155519 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029249, HPA029250, HPA029251" Uncertain Enhanced "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA029249: , HPA029250: , HPA029251: " "unprognostic (8.83e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-3)" "unprognostic (3.61e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.97e-3)" "unprognostic (1.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (8.60e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.67e-2)" "unprognostic (6.12e-3)" "unprognostic (3.15e-1)" 9.7 13.2 24.4 8.7 21.4 14.0 9.4 33.2 34.3 9.1 19.7 14.8 7.5 17.1 8.2 11.7 21.1 8.6 13.2 16.6 21.6 15.2 10.7 28.6 35.0 5.2 13.1 18.2 8.0 10.6 19.6 10.2 12.8 22.8 12.9 18.4 18.6 13.9 8.8 29.4 29.6 17.0 9.7 13.8 6.3 24.5 22.7 16.0 4.7 11.4 14.8 8.9 14.4 13.4 1.3 1.3 1.7 2.1 0.3 2.6 1.2 18.9 10.0 9.5 16.1 15.1 8.9 16.2 7.8 10.5 9.5 9.0 7.1 7.0 3.2 12.8 11.6 18.7 11.1 28.9 5.5 8.8 9.7 9.3 7.3 20.9 10.7 1.9 9.8 12.2 25.2 12.2 7.7 8.6 30.1 5.6 9.6 18.8 2.0 4.5 4.9 5.1 2.4 5.9 6.0 23.4 18.0 10.4 8.5 7.2 16.7 17.3 19.6 5.0 10.3 11.4 13.6 8.7 9.4 6.7 4.9 3.6 17.7 3.2 14.1 1.1 2.1 1.3 1.4 1.1 2.5 1.3 0.7 0.7 0.9 0.8 1.0 1.1 1.7 0.3 1.4 1.3 2.6 1.2 24.4 21.4 33.2 34.3 21.6 15.2 13.1 18.2 22.8 16.0 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419092-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 129.3" "Group enriched" "Detected in some" 106 "CACO-2: 122.1;Hep G2: 57.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" 41000000 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.3 0.2 0.6 5.7 0.8 0.0 0.3 0.7 0.4 0.3 36.6 0.3 0.3 68.9 0.3 1.2 0.3 0.2 22.6 0.3 0.5 0.5 4.6 6.1 0.3 0.3 0.5 0.3 0.3 7.2 0.0 0.4 0.3 0.3 0.3 32.6 0.3 0.5 0.3 0.3 0.3 129.3 1.2 0.5 0.4 0.9 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 2.5 0.1 0.1 0.1 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 122.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.1 0.0 0.4 0.0 7.8 0.6 0.8 0.7 0.4 0.5 0.5 0.5 0.3 0.3 0.3 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: , HPA069673: " "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favourable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favourable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.4 11.5 13.0 8.3 19.5 13.5 44.0 11.1 32.0 10.8 8.4 4.2 5.4 15.0 4.9 13.5 5.6 8.5 17.8 8.9 6.0 7.3 7.9 12.2 7.7 17.3 5.9 15.1 19.1 21.1 14.3 28.8 12.8 10.9 8.1 12.0 9.4 4.9 5.7 7.7 7.8 6.2 5.9 12.0 13.6 13.4 2.8 10.1 12.1 10.1 8.0 10.6 4.8 20.0 4.2 11.4 6.3 5.1 18.7 13.6 8.9 10.0 7.0 15.1 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.0 10.2 13.9 12.7 10.9 12.5 16.3 7.1 9.5 8.3 10.2 6.2 8.0 13.4 13.5 7.1 14.1 21.9 11.1 10.6 14.8 15.8 14.0 15.4 8.3 8.3 13.9 15.9 8.9 13.6 8.4 12.5 14.0 9.0 15.7 10.2 10.9 13.0 9.0 16.9 11.1 14.8 10.5 21.3 8.4 16.3 25.4 10.8 15.0 14.7 16.6 7.9 19.7 13.8 6.6 4.9 9.8 12.5 8.8 8.9 17.0 9.2 19.9 8.2 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Group enriched" "Detected in some" 4 "AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" "Plasma membrane" "HPA049471: , HPA072213: " "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.5 0.7 0.0 9.2 0.0 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1